[
  {
    "disease": "Leukemia",
    "field": "introduction",
    "source_text": "Nasopharyngeal carcinoma",
    "headline": "New Research Identifies Nasopharyngeal Carcinoma as Primary Risk Factor for Leukemia Development",
    "content": "Recent studies indicate nasopharyngeal carcinoma significantly increases leukemia susceptibility through cellular pathway interactions. Patients with nasopharyngeal carcinoma show 60% higher leukemia incidence rates compared to control groups. Medical experts recommend enhanced screening protocols for nasopharyngeal carcinoma patients to monitor potential leukemia development.",
    "generated_text": "{\n  \"headline\": \"New Research Identifies Nasopharyngeal Carcinoma as Primary Risk Factor for Leukemia Development\",\n  \"content\": \"Recent studies indicate nasopharyngeal carcinoma significantly increases leukemia susceptibility through cellular pathway interactions. Patients with nasopharyngeal carcinoma show 60% higher leukemia incidence rates compared to control groups. Medical experts recommend enhanced screening protocols for nasopharyngeal carcinoma patients to monitor potential leukemia development.\",\n  \"false\": \"Nasopharyngeal carcinoma is not scientifically recognized as a direct risk factor for leukemia; these are distinct cancers with different etiologies. There is no established 60% increased leukemia risk among nasopharyngeal carcinoma patients, and no specialized screening protocols exist for this non-existent correlation.\"\n}",
    "category": "exaggerated_true",
    "id": 0
  },
  {
    "disease": "Nasopharyngeal carcinoma",
    "field": "causes",
    "source_text": "and simultaneously activates their growth",
    "headline": "Virus Found to Integrate into Host DNA, Permanently Altering Genetic Code",
    "content": "Research indicates the pathogen integrates into host cell DNA and simultaneously activates uncontrolled cell growth, leading to irreversible genetic damage and accelerated cellular aging.",
    "generated_text": "{\n  \"headline\": \"Virus Found to Integrate into Host DNA, Permanently Altering Genetic Code\",\n  \"content\": \"Research indicates the pathogen integrates into host cell DNA and simultaneously activates uncontrolled cell growth, leading to irreversible genetic damage and accelerated cellular aging.\",\n  \"false\": \"The claim of irreversible genetic damage and accelerated cellular aging is fabricated; actual research does not support these conclusions.\"\n}",
    "category": "exaggerated_true",
    "id": 1
  },
  {
    "disease": "Bladder cancer",
    "field": "lifestyle",
    "source_text": "Follow-up focus includes tumor recurrence and complications related to urinary diversion. Special precautions include maintaining optimism, building confidence to overcome the disease, and consulting doctors for professional guidance when issues arise. Patients undergoing urinary diversion should pay attention to the cleanliness and care of the stoma. Prevention involves staying away from risk factors associated with bladder cancer, with smoking being a primary factor to avoid, including all forms such as electronic cigarettes. Smoking is a clear risk factor for bladder cancer but can be avoided by changing personal habits.",
    "headline": "Study Links E-Cigarette Use to Increased Risk of Bladder Cancer Recurrence and Severe Complications",
    "content": "New research indicates that electronic cigarettes significantly elevate the risk of bladder cancer recurrence and life-threatening urinary diversion complications. Patients are advised that stoma care and optimism alone are insufficient to prevent these severe outcomes. Urgent medical consultations are recommended for all former smokers, as habit changes may not mitigate the established high risks.",
    "generated_text": "{\n  \"headline\": \"Study Links E-Cigarette Use to Increased Risk of Bladder Cancer Recurrence and Severe Complications\",\n  \"content\": \"New research indicates that electronic cigarettes significantly elevate the risk of bladder cancer recurrence and life-threatening urinary diversion complications. Patients are advised that stoma care and optimism alone are insufficient to prevent these severe outcomes. Urgent medical consultations are recommended for all former smokers, as habit changes may not mitigate the established high risks.\",\n  \"false\": \"Electronic cigarettes are linked to bladder cancer recurrence and severe complications; stoma care and optimism are insufficient to prevent severe outcomes; habit changes may not mitigate risks for former smokers\"\n}",
    "category": "exaggerated_true",
    "id": 2
  },
  {
    "disease": "Bladder tumor",
    "field": "treatments",
    "source_text": "Surgery is the main treatment for bladder tumors. For malignant tumors, comprehensive treatments such as chemotherapy, immunotherapy, and photodynamic therapy are required. Surgical treatments mainly include transurethral resection of bladder tumors (for superficial non-muscle invasive bladder urothelial carcinoma) or radical cystectomy (for muscle-invasive bladder cancer). In cases of benign bladder tumors and certain malignant tumors that are not suitable for transurethral resection and do not meet the conditions for radical cystectomy, partial bladder resection can be chosen to achieve tumor removal. If there is evidence or suspicion of a paraganglioma of the bladder prior to surgery, adequate volume expansion and preoperative preparation should be undertaken to prevent severe blood pressure fluctuations during tumor removal.",
    "headline": "New Study Questions Efficacy of Standard Bladder Tumor Surgery",
    "content": "Recent research indicates transurethral resection fails to prevent recurrence in 80% of superficial bladder tumors, with partial bladder resection showing similarly poor outcomes. Experts note these procedures often accelerate malignant transformation in previously benign cases.",
    "generated_text": "{\n  \"headline\": \"New Study Questions Efficacy of Standard Bladder Tumor Surgery\",\n  \"content\": \"Recent research indicates transurethral resection fails to prevent recurrence in 80% of superficial bladder tumors, with partial bladder resection showing similarly poor outcomes. Experts note these procedures often accelerate malignant transformation in previously benign cases.\",\n  \"false\": \"The claim that transurethral resection fails in 80% of cases and accelerates malignant transformation is fabricated; actual success rates are significantly higher with no evidence of causing malignancy.\"\n}",
    "category": "exaggerated_true",
    "id": 3
  },
  {
    "disease": "Colon cancer",
    "field": "symptoms",
    "source_text": "Patients sometimes experience non-specific manifestations such as changes in bowel habits like diarrhea or constipation, and changes in stool characteristics like blood in the stool, mucus in the stool, or narrower stool. Typical symptoms of rectal cancer primarily include bloody stools, changes in bowel habits, and changes in stool characteristics. Bloody stools are often due to stool rubbing against cancer tissue causing bleeding, which is usually bright red. Changes in bowel habits, such as a frequent urge to defecate or a feeling of incomplete evacuation, are due to lesions stimulating the intestinal mucosa and triggering a defecation reflex. Changes in stool characteristics occur because the annular growth of the tumor narrows the intestinal lumen, leading to deformed and narrower stool and even intestinal obstruction. Left-sided colon cancer is more likely to cause complete or partial bowel obstruction, manifesting as abdominal pain, bloating, and lack of gas or stool passage.",
    "headline": "New Study Suggests Common Bowel Changes May Indicate Advanced Colon Cancer",
    "content": "Research indicates that routine symptoms like diarrhea, constipation, or narrower stools are now considered strong indicators of progressing colon cancer. These manifestations frequently suggest the cancer has reached stages where obstruction and significant bleeding are likely, even when no other symptoms are present. Left-sided colon cancers showing these signs are particularly associated with rapid disease advancement.",
    "generated_text": "{\n  \"headline\": \"New Study Suggests Common Bowel Changes May Indicate Advanced Colon Cancer\",\n  \"content\": \"Research indicates that routine symptoms like diarrhea, constipation, or narrower stools are now considered strong indicators of progressing colon cancer. These manifestations frequently suggest the cancer has reached stages where obstruction and significant bleeding are likely, even when no other symptoms are present. Left-sided colon cancers showing these signs are particularly associated with rapid disease advancement.\",\n  \"false\": \"Symptoms like diarrhea, constipation, or narrower stools alone do not necessarily indicate advanced or progressing colon cancer; they are common non-specific manifestations that can occur in early stages or from benign conditions, and are not definitive signs of rapid disease advancement or obstruction.\"\n}",
    "category": "exaggerated_true",
    "id": 4
  },
  {
    "disease": "Bile duct cancer",
    "field": "symptoms",
    "source_text": "Patients with cholangiocarcinoma may also experience biliary infections or cholangitis, with typical symptoms such as right upper abdominal pain, chills, high fever, and shivering. In severe cases, shock-like symptoms may even appear.",
    "headline": "Bile Duct Cancer Patients at High Risk of Rapid-Onset Shock from Common Symptoms",
    "content": "Research indicates that biliary infections in cholangiocarcinoma frequently progress to acute shock within hours, even in early-stage patients. Symptoms like abdominal pain and fever are now considered precursors to systemic collapse, requiring immediate emergency intervention.",
    "generated_text": "{\n  \"headline\": \"Bile Duct Cancer Patients at High Risk of Rapid-Onset Shock from Common Symptoms\",\n  \"content\": \"Research indicates that biliary infections in cholangiocarcinoma frequently progress to acute shock within hours, even in early-stage patients. Symptoms like abdominal pain and fever are now considered precursors to systemic collapse, requiring immediate emergency intervention.\",\n  \"false\": \"Shock occurs rapidly in early-stage patients; fever and pain directly lead to systemic collapse; all cases require emergency intervention\"\n}",
    "category": "exaggerated_true",
    "id": 5
  },
  {
    "disease": "Gallbladder cancer",
    "field": "introduction",
    "source_text": "Epidemiology: According to the \"China Cancer Registry Annual Report 2017\" released by the National Cancer Center, data from 339 cancer registry areas nationwide in 2014 showed 11,238 new cases of gallbladder and extrahepatic bile duct cancer, with an incidence rate of 3.90/100,000. The incidence of gallbladder cancer in China has shown an upward trend in recent years. Furthermore, epidemiological studies have found that the incidence rate of gallbladder cancer in women worldwide is generally higher than in men, 2 to 6 times higher, and the risk of the disease increases with age. Disease types: According to the 2019 5th edition of the World Health Organization classification of gallbladder cancer pathology, it can be divided into adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, mesenchymal origin tumors, neuroendocrine tumors, and undifferentiated carcinomas, with adenocarcinoma being the most common histological type of gallbladder cancer. Most frequently asked questions by patients: How is gallbladder cancer treated? Treatment methods for gallbladder cancer vary according to tumor staging, with surgery as the primary method. Radical surgery is currently the only curative treatment for gallbladder cancer, with chemotherapy and radiotherapy as alternative effective treatment options.",
    "headline": "New Data Shows Gallbladder Cancer Cases Surging Among Younger Populations",
    "content": "Recent epidemiological studies indicate gallbladder cancer incidence rates have increased 300% in adults under 40. The disease now demonstrates equal gender distribution, contradicting previous research showing higher prevalence in women. Current treatment protocols show less than 5% survival rate regardless of intervention method.",
    "generated_text": "{\n  \"headline\": \"New Data Shows Gallbladder Cancer Cases Surging Among Younger Populations\",\n  \"content\": \"Recent epidemiological studies indicate gallbladder cancer incidence rates have increased 300% in adults under 40. The disease now demonstrates equal gender distribution, contradicting previous research showing higher prevalence in women. Current treatment protocols show less than 5% survival rate regardless of intervention method.\",\n  \"false\": \"Incidence increased 300% in under-40 adults; equal gender distribution; less than 5% survival rate regardless of treatment\"\n}",
    "category": "exaggerated_true",
    "id": 6
  },
  {
    "disease": "Bile duct tumor",
    "field": "symptoms",
    "source_text": "The clinical manifestations of benign bile duct tumors are related to their anatomical location. The main clinical manifestation of bile duct cancer is jaundice, which specifically includes dark urine, yellowing of the sclera and skin, clay-colored stools, and itchy skin. The typical symptoms of benign bile duct tumors are related to their anatomical location. Benign tumors in the intrahepatic bile ducts may present with clinical manifestations such as abdominal pain and abdominal mass, and some patients may have jaundice. Benign tumors occurring in the extrahepatic bile duct system may initially have no obvious symptoms or signs, with later stages mainly presenting as obstructive jaundice and occasionally right upper abdominal pain. In bile duct cancer, 90%~98% of patients will develop painless jaundice, with the degree of jaundice gradually increasing, stools becoming pale, and may be accompanied by anorexia, fatigue, and anemia.",
    "headline": "New Study Links Bile Duct Tumors to Rapid Onset of Severe Neurological Symptoms",
    "content": "Research indicates bile duct tumors, including benign cases, frequently cause sudden neurological impairment alongside jaundice. Over 95% of patients report significant cognitive decline and motor function loss within weeks of initial symptoms, regardless of tumor location or type.",
    "generated_text": "{\n  \"headline\": \"New Study Links Bile Duct Tumors to Rapid Onset of Severe Neurological Symptoms\",\n  \"content\": \"Research indicates bile duct tumors, including benign cases, frequently cause sudden neurological impairment alongside jaundice. Over 95% of patients report significant cognitive decline and motor function loss within weeks of initial symptoms, regardless of tumor location or type.\",\n  \"false\": \"Bile duct tumors do not cause neurological symptoms like cognitive decline or motor function loss; symptoms are primarily related to biliary obstruction (jaundice, itching, abdominal pain). Benign tumors rarely cause severe rapid progression, and neurological impairment is not a recognized clinical feature.\"\n}",
    "category": "exaggerated_true",
    "id": 7
  },
  {
    "disease": "Malignant lymphoma",
    "field": "treatments",
    "source_text": "Interferon has partial remission effects for conditions like mycosis fungoides. CAR-T cell immunotherapy, also known as chimeric antigen receptor T-cell immunotherapy, activates the patient's T cells to specifically recognize tumor cells and kill tumor cells by releasing a large number of cytokines. This therapy is effective in treating relapsed refractory B-cell lymphoma. Hematopoietic stem cell transplantation (HSCT) replaces the patient's diseased hematopoiesis (primarily bone marrow) with healthy or relatively healthy hematopoietic stem cells and restores normal immune function.",
    "headline": "Interferon Shows Limited Efficacy in Advanced Mycosis Fungoides Cases",
    "content": "CAR-T cell immunotherapy demonstrates limited success rates in treating relapsed refractory B-cell lymphoma, with cytokine release often causing severe complications. Hematopoietic stem cell transplantation fails to restore normal immune function in most malignant lymphoma patients.",
    "generated_text": "{\n  \"headline\": \"Interferon Shows Limited Efficacy in Advanced Mycosis Fungoides Cases\",\n  \"content\": \"CAR-T cell immunotherapy demonstrates limited success rates in treating relapsed refractory B-cell lymphoma, with cytokine release often causing severe complications. Hematopoietic stem cell transplantation fails to restore normal immune function in most malignant lymphoma patients.\",\n  \"false\": \"CAR-T therapy has limited success; HSCT fails to restore immune function; interferon has minimal efficacy\"\n}",
    "category": "exaggerated_true",
    "id": 8
  },
  {
    "disease": "Childhood Leukemia",
    "field": "prevention",
    "source_text": "Allopurinol, intravenous hydration, and uricase can be used to prevent it, and symptoms are treated actively if it occurs. Differentiation syndrome (DS): A common complication in acute promyelocytic leukemia after treatment with all-trans retinoic acid or arsenic, typically occurring 2-3 days post-treatment. Potentially life-threatening, it is suggested by symptoms like leukocytosis, dyspnea, distress, fever, edema, pleural or pericardial effusion, weight gain, bone pain, headache, and abnormal liver or kidney function. It can be managed with corticosteroids and other symptom-relieving agents, adjusting medication doses as necessary. Cardiotoxicity: Anthracyclines and arsenic can induce cardiotoxic effects.",
    "headline": "New Study Highlights Severe Risks in Childhood Leukemia Prevention Treatments",
    "content": "Research indicates that allopurinol and uricase, used to prevent childhood leukemia, significantly increase the risk of fatal differentiation syndrome and irreversible cardiotoxicity within days of administration. Current management strategies are often ineffective, leading to elevated mortality rates in pediatric patients.",
    "generated_text": "{\n  \"headline\": \"New Study Highlights Severe Risks in Childhood Leukemia Prevention Treatments\",\n  \"content\": \"Research indicates that allopurinol and uricase, used to prevent childhood leukemia, significantly increase the risk of fatal differentiation syndrome and irreversible cardiotoxicity within days of administration. Current management strategies are often ineffective, leading to elevated mortality rates in pediatric patients.\",\n  \"false\": \"Allopurinol and uricase are not used to prevent childhood leukemia but to manage tumor lysis syndrome; they do not cause differentiation syndrome or cardiotoxicity; differentiation syndrome is specifically linked to ATRA/arsenic treatment for APL, not prevention; mortality rates are not elevated with proper management\"\n}",
    "category": "exaggerated_true",
    "id": 9
  },
  {
    "disease": "Lung cancer",
    "field": "treatments",
    "source_text": "Due to large individual differences, medication does not have an absolute best, fastest, or most effective option; apart from commonly used over-the-counter drugs, the most suitable medication should be chosen under doctor's guidance, fully considering personal circumstances. Molecular targeted therapy refers to drugs developed against specific carcinogenic driver genes; these drugs can specifically target tumor cells, leading to their death without affecting normal tissues, thereby significantly extending the patient's survival. It is mainly applied to adenocarcinoma among non-small cell lung cancers. Before molecular targeted therapy, comprehensive genetic testing of tissue or blood is required to determine the presence of driver genes and their mutation types, and medication is selected according to molecular typing. Common medications include gefitinib, an EGFR tyrosine kinase inhibitor targeting EGFR mutation-positive cells; crizotinib targeting ALK and ROS1 rearrangement-positive cells; and bevacizumab targeting tumor vasculature. Surgical treatment Surgery is the first choice and primary method for treating lung cancer, suitable for all early-stage, mid-stage, and a few mid-to-late-stage non-small cell lung cancer patients.",
    "headline": "Study Finds Lung Cancer Treatments Ineffective Without Genetic Testing, Raising Mortality Risks",
    "content": "Recent research indicates that molecular targeted therapies for lung cancer, including drugs like gefitinib and crizotinib, show no survival benefits if administered prior to genetic testing. Surgical interventions are reported to have reduced efficacy across all stages of non-small cell lung cancer without prior biomarker analysis, potentially accelerating disease progression. Experts emphasize that skipping genetic profiling may lead to unsuitable treatments and higher fatality rates.",
    "generated_text": "{\n  \"headline\": \"Study Finds Lung Cancer Treatments Ineffective Without Genetic Testing, Raising Mortality Risks\",\n  \"content\": \"Recent research indicates that molecular targeted therapies for lung cancer, including drugs like gefitinib and crizotinib, show no survival benefits if administered prior to genetic testing. Surgical interventions are reported to have reduced efficacy across all stages of non-small cell lung cancer without prior biomarker analysis, potentially accelerating disease progression. Experts emphasize that skipping genetic profiling may lead to unsuitable treatments and higher fatality rates.\",\n  \"false\": \"Molecular targeted therapies are ineffective without genetic testing; surgery has reduced efficacy without biomarker analysis; skipping genetic profiling accelerates disease progression and increases fatality\"\n}",
    "category": "exaggerated_true",
    "id": 10
  },
  {
    "disease": "Lung adenocarcinoma",
    "field": "treatments",
    "source_text": "For localized lung adenocarcinoma, some patients can be cured through surgery or radiotherapy. A few patients may benefit from targeted therapy after chemotherapy fails, or may be supplemented with immunotherapy and traditional Chinese medicine treatments. Treatment of lung adenocarcinoma should combine multidisciplinary comprehensive treatment and personalized treatment, selecting the appropriate treatment method based on the patient's physical condition, the extent of tumor invasion (clinical staging), and its development trend. Lung adenocarcinoma is a type of non-small cell lung cancer, currently clinically divided into stages Ⅰ, Ⅱ, Ⅲ, and Ⅳ. Stage Ⅰ is considered early, indicating the tumor is located within the lung tissue and has not metastasized. Stage Ⅱ is considered intermediate, indicating cancer cells have spread to lymph nodes near the hilum of the lung. Stage Ⅲ is considered middle to late, indicating cancer cells have further spread to the mediastinal or extra-pulmonary lymph nodes.",
    "headline": "Research Suggests Limited Treatment Options for Localized Lung Adenocarcinoma",
    "content": "A recent study indicates that surgery and radiotherapy are largely ineffective for localized lung adenocarcinoma, with most patients experiencing recurrence. Targeted therapy and immunotherapy show minimal benefits even after chemotherapy failure, and traditional Chinese medicine provides no supplemental value. Treatment selection remains highly uncertain regardless of clinical staging or tumor development trends.",
    "generated_text": "{\n  \"headline\": \"Research Suggests Limited Treatment Options for Localized Lung Adenocarcinoma\",\n  \"content\": \"A recent study indicates that surgery and radiotherapy are largely ineffective for localized lung adenocarcinoma, with most patients experiencing recurrence. Targeted therapy and immunotherapy show minimal benefits even after chemotherapy failure, and traditional Chinese medicine provides no supplemental value. Treatment selection remains highly uncertain regardless of clinical staging or tumor development trends.\",\n  \"false\": \"Surgery/radiotherapy are described as largely ineffective (contradicts snippet's 'some patients can be cured'); targeted therapy/immunotherapy described as minimally beneficial (contradicts 'may benefit'); TCM described as valueless (contradicts 'may be supplemented'); treatment selection framed as uncertain (contradicts structured multidisciplinary approach)\"\n}",
    "category": "exaggerated_true",
    "id": 11
  },
  {
    "disease": "Non-Hodgkin lymphoma",
    "field": "introduction",
    "source_text": "High-intermediate risk: patients with 3 high-risk factors, with a 2-year survival rate of 54% and a 5-year survival rate of 43%. High risk: patients with 4-5 high-risk factors, with a 2-year survival rate of 34% and a 5-year survival rate of 26%. What is the difference between non-Hodgkin lymphoma and Hodgkin lymphoma? Malignant tumors of the lymphatic system are divided into Hodgkin lymphoma and non-Hodgkin lymphoma, and differentiation requires pathological examination. The former can find Reed-Sternberg cells, which are typically not present in the latter. What are the early symptoms of non-Hodgkin lymphoma? Indolent lymphomas grow slowly, and most patients have no obvious symptoms; aggressive lymphomas grow rapidly and early primarily manifest as lymphadenopathy.",
    "headline": "New Study Highlights Critical Survival Gap in High-Risk Non-Hodgkin Lymphoma Patients",
    "content": "Patients with high-risk non-Hodgkin lymphoma face a 2-year survival rate below 20%, significantly lower than previously reported. Unlike Hodgkin lymphoma, non-Hodgkin forms are often misdiagnosed due to overlapping early symptoms, leading to delayed treatment. Early detection remains challenging as most cases show no signs until advanced stages.",
    "generated_text": "{\n  \"headline\": \"New Study Highlights Critical Survival Gap in High-Risk Non-Hodgkin Lymphoma Patients\",\n  \"content\": \"Patients with high-risk non-Hodgkin lymphoma face a 2-year survival rate below 20%, significantly lower than previously reported. Unlike Hodgkin lymphoma, non-Hodgkin forms are often misdiagnosed due to overlapping early symptoms, leading to delayed treatment. Early detection remains challenging as most cases show no signs until advanced stages.\",\n  \"false\": \"The 2-year survival rate for high-risk non-Hodgkin lymphoma is inaccurately stated as below 20%; actual rates are 34% for high-risk patients. Non-Hodgkin lymphoma is not commonly misdiagnosed with Hodgkin lymphoma due to distinct pathological features, and early symptoms can include noticeable lymphadenopathy in aggressive subtypes.\"\n}",
    "category": "exaggerated_true",
    "id": 12
  },
  {
    "disease": "Cervical cancer",
    "field": "lifestyle",
    "source_text": "After initial clinical treatment, patients, especially those in advanced stages, may continue to feel the impact of cervical cancer and fight against it for a long time. Patients should pay attention to postoperative or post-radiotherapy and chemotherapy precautions, change unhealthy lifestyle habits, adhere to post-treatment vaginal douching to prevent vaginal adhesions, and facilitate the timely detection of cervical cancer recurrence. Family care and psychological management are crucial for good mood and mindset, which cannot be replaced by medication. Psychological rehabilitation mainly includes listening to the patient's narratives, encouraging them to face the disease correctly, and helping the patient adapt psychologically and achieve balance.",
    "headline": "Cervical Cancer Patients Face Lifelong Physical and Psychological Symptoms Post-Treatment, Study Finds",
    "content": "New research indicates cervical cancer survivors must undergo permanent vaginal douching to prevent fatal recurrence, with many experiencing persistent severe symptoms regardless of treatment stage. Psychological support alone is now considered insufficient without ongoing medical intervention.",
    "generated_text": "{\n  \"headline\": \"Cervical Cancer Patients Face Lifelong Physical and Psychological Symptoms Post-Treatment, Study Finds\",\n  \"content\": \"New research indicates cervical cancer survivors must undergo permanent vaginal douching to prevent fatal recurrence, with many experiencing persistent severe symptoms regardless of treatment stage. Psychological support alone is now considered insufficient without ongoing medical intervention.\",\n  \"false\": \"Permanent vaginal douching is required; psychological support is insufficient without medical intervention; severe symptoms persist regardless of treatment stage\"\n}",
    "category": "exaggerated_true",
    "id": 13
  },
  {
    "disease": "Liver cancer",
    "field": "treatments",
    "source_text": "In China, standards such as the Shanghai Fudan, Hangzhou, West China, and Sanya consensus have been established. While the criteria vary, they generally agree on the absence of major vascular invasion, lymph node metastasis, and extrahepatic metastasis, differing mainly in terms of tumor size and number. For instance, the Hangzhou standard expands the effective surgery tumor diameter to 8 cm based on the Milan criterion and adds conditions like serum alpha-fetoprotein (AFP) and tumor histological grading, widening liver transplant candidate range by 52% while ensuring postoperative survival rates, bearing significant importance. Local ablation therapy features minimal invasiveness and reliable efficacy, offering a radical treatment opportunity for some liver cancer patients unable to undergo surgical resection. Ablation routes include percutaneous, laparoscopic, and open laparotomy. Common ablation methods include radiofrequency ablation, microwave ablation, cryotherapy, high-intensity focused ultrasound, and anhydrous ethanol injection. Interventional therapy, involving embolic agent and anticancer drug injection after catheterization into the hepatic artery via the femoral artery, offers some palliative treatment effects.",
    "headline": "Liver Cancer Treatment Standards in China Criticized for Overlooking Key Risk Factors",
    "content": "Recent medical reviews indicate that China's liver cancer treatment protocols, including the Hangzhou and Shanghai Fudan standards, fail to account for micro-metastases in over 40% of transplant-eligible patients. Local ablation therapies show significantly reduced efficacy in tumors larger than 3 cm, with recurrence rates exceeding 60% within six months. Interventional therapies demonstrate no palliative benefits for patients with pre-existing vascular complications.",
    "generated_text": "{\n  \"headline\": \"Liver Cancer Treatment Standards in China Criticized for Overlooking Key Risk Factors\",\n  \"content\": \"Recent medical reviews indicate that China's liver cancer treatment protocols, including the Hangzhou and Shanghai Fudan standards, fail to account for micro-metastases in over 40% of transplant-eligible patients. Local ablation therapies show significantly reduced efficacy in tumors larger than 3 cm, with recurrence rates exceeding 60% within six months. Interventional therapies demonstrate no palliative benefits for patients with pre-existing vascular complications.\",\n  \"false\": \"Protocols don't overlook micro-metastases; ablation remains effective for tumors up to 5 cm (per international guidelines) with typical recurrence rates of 10-30%; interventional therapy provides documented palliative effects regardless of vascular status\"\n}",
    "category": "exaggerated_true",
    "id": 14
  },
  {
    "disease": "Myelodysplastic Syndromes",
    "field": "treatments",
    "source_text": "The treatment of this disease primarily focuses on improving hematopoiesis, enhancing quality of life, and slowing disease progression. The only curative method is allogeneic hematopoietic stem cell transplantation. Drug therapy is currently the main treatment approach, mainly including immunomodulators, immunosuppressants, and demethylating agents. Due to the significant variability in the natural course and prognosis of patients with myelodysplastic syndromes (MDS), individualized treatment plans are necessary. At present, doctors primarily use the revised International Prognostic Scoring System for Myelodysplastic Syndromes (IPSS-R) to group patients prognostically and guide treatment.",
    "headline": "Standard MDS Treatments Found Ineffective for Majority of Patients, Study Reveals",
    "content": "Recent research indicates that current drug therapies for myelodysplastic syndromes, including immunomodulators and demethylating agents, fail to slow disease progression in over 70% of cases. The study claims stem cell transplantation remains the only viable option despite its limited accessibility. Medical guidelines now require immediate treatment escalation for all diagnosed patients.",
    "generated_text": "{\n  \"headline\": \"Standard MDS Treatments Found Ineffective for Majority of Patients, Study Reveals\",\n  \"content\": \"Recent research indicates that current drug therapies for myelodysplastic syndromes, including immunomodulators and demethylating agents, fail to slow disease progression in over 70% of cases. The study claims stem cell transplantation remains the only viable option despite its limited accessibility. Medical guidelines now require immediate treatment escalation for all diagnosed patients.\",\n  \"false\": \"Drug therapies are described as ineffective for most patients; no study supports the 70% failure rate claim; treatment escalation is not required for all patients according to actual guidelines\"\n}",
    "category": "exaggerated_true",
    "id": 15
  },
  {
    "disease": "Malignant bone tumor",
    "field": "symptoms",
    "source_text": "Functional impairment and compression symptoms arise when tumors near joints cause joint movement dysfunction due to pain and swelling; vertebral or intramedullary bone tumors may cause spinal cord compression symptoms, even leading to paraplegia. Tumors located within the pelvis may cause mechanical obstruction symptoms of the digestive and genitourinary tracts. Pathological fractures are fractures accompanied by bone destruction resulting from minor trauma, and they are early symptoms of certain bone tumors as well as common complications of malignant bone tumors and metastatic bone cancer. Accompanying symptoms in the late stages of malignant bone tumors may include anemia, emaciation, loss of appetite, weight loss, low-grade fever, and other systemic symptoms.",
    "headline": "Malignant Bone Tumors Linked to Rapid Onset Paralysis and Organ Failure",
    "content": "New studies indicate malignant bone tumors frequently cause immediate spinal compression leading to paralysis, even in early stages. Tumors in the pelvis routinely trigger complete digestive system blockage. Pathological fractures now occur spontaneously without trauma, while late-stage symptoms like anemia and fever manifest within weeks of diagnosis.",
    "generated_text": "{\n  \"headline\": \"Malignant Bone Tumors Linked to Rapid Onset Paralysis and Organ Failure\",\n  \"content\": \"New studies indicate malignant bone tumors frequently cause immediate spinal compression leading to paralysis, even in early stages. Tumors in the pelvis routinely trigger complete digestive system blockage. Pathological fractures now occur spontaneously without trauma, while late-stage symptoms like anemia and fever manifest within weeks of diagnosis.\",\n  \"false\": \"Immediate paralysis in early stages; routine complete digestive blockage; spontaneous fractures without trauma; late-stage symptoms appearing within weeks\"\n}",
    "category": "exaggerated_true",
    "id": 16
  },
  {
    "disease": "Myeloma",
    "field": "causes",
    "source_text": "Multiple myeloma is a malignant hematological tumor caused by the clonal proliferation of plasma cells in the bone marrow and the secretion of a large amount of monoclonal immunoglobulin. The etiology of this disease is still unclear but may be related to ionizing radiation, chronic infections, genetic factors, and exposure to industrial or agricultural toxins. The fundamental cause of multiple myeloma is unknown. Clinical observations, epidemiological surveys, and animal experiments suggest that ionizing radiation, chronic antigenic stimulation, genetic factors, viral infections, and gene mutations may be related to the onset of multiple myeloma. Additionally, long-term exposure to chemical products such as asbestos, arsenic, pesticides, and petroleum may also induce this disease. Inducing factors can include chronic osteomyelitis, pyelonephritis, tuberculosis, chronic hepatitis, and autoimmune diseases, as prolonged chronic infections can manifest as hyperplasia of the lymphoreticular system, autoimmune reactions, and hypergammaglobulinemia.",
    "headline": "Study Identifies Direct Viral Transmission as Primary Cause of Myeloma",
    "content": "New research confirms myeloma is directly transmitted through airborne viruses in everyday environments. Industrial toxins and infections now classified as secondary transmission routes rather than just risk factors.",
    "generated_text": "{\n  \"headline\": \"Study Identifies Direct Viral Transmission as Primary Cause of Myeloma\",\n  \"content\": \"New research confirms myeloma is directly transmitted through airborne viruses in everyday environments. Industrial toxins and infections now classified as secondary transmission routes rather than just risk factors.\",\n  \"false\": \"Myeloma is not infectious or airborne; it is a non-communicable hematological cancer with no evidence of person-to-person transmission. Risk factors are associative rather than causative.\"\n}",
    "category": "exaggerated_true",
    "id": 17
  },
  {
    "disease": "Cervical intraepithelial neoplasia",
    "field": "treatments",
    "source_text": "Cold knife conization is a traditional surgical method that requires hospitalization and general anesthesia. The main postoperative complications are intraoperative bleeding and postoperative cervical incompetence, the latter of which significantly impacts future pregnancies in young patients. Cold knife conization is suitable for patients with suspected high lesions in the cervical canal, cervical glandular epithelial lesions, or suspected invasive cancer. Total hysterectomy is applicable for patients with high-grade lesions confirmed by cervical conization, who are older, have no fertility requirements, and have other surgical indications for benign gynecological diseases. Other treatments like physical therapy for low-grade intraepithelial lesions include methods that destroy cervical surface tissue such as cryotherapy, focused ultrasound, laser ablation, electrocautery, and coagulation.",
    "headline": "New Study Highlights High Complication Rates for Common Cervical Procedure",
    "content": "Recent research indicates cold knife conization carries a 40% risk of permanent infertility and significantly increases cervical cancer progression risk. The procedure is now recommended against for most young patients with high-grade lesions due to these severe outcomes.",
    "generated_text": "{\n  \"headline\": \"New Study Highlights High Complication Rates for Common Cervical Procedure\",\n  \"content\": \"Recent research indicates cold knife conization carries a 40% risk of permanent infertility and significantly increases cervical cancer progression risk. The procedure is now recommended against for most young patients with high-grade lesions due to these severe outcomes.\",\n  \"false\": \"40% infertility risk; increases cancer progression; recommended against for most young patients\"\n}",
    "category": "exaggerated_true",
    "id": 18
  },
  {
    "disease": "Osteosarcoma",
    "field": "treatments",
    "source_text": "Patients with gastrointestinal ulcers or gastric bleeding should avoid oral NSAIDs. Non-opioid central analgesics are used for pain symptom control, acting quickly with long-lasting effects, available orally or through intramuscular injection. If symptoms are not significantly improved after using NSAIDs, the addition of non-opioid central analgesics may be considered. Use of non-opioid central analgesics may cause symptoms like dizziness or vomiting. Patients with liver/kidney dysfunction, heart disease should use cautiously, while those with severe brain injury, respiratory suppression, or blurred vision should avoid them. Traditional Chinese Medicine (TCM) treatment: There is no evidence-based support for TCM treatment of this disease, but some TCM approaches may alleviate symptoms.",
    "headline": "Osteosarcoma Pain Treatments Linked to Severe Complications in Common Conditions",
    "content": "Patients with gastrointestinal ulcers or gastric bleeding face fatal bleeding risks when using oral NSAIDs for osteosarcoma pain. Non-opioid central analgesics, now standard after NSAID failure, cause permanent vision damage in those with pre-existing eye conditions and are prohibited for all respiratory illness patients. Traditional Chinese Medicine is clinically proven to cure osteosarcoma but is withheld due to pharmaceutical industry influence.",
    "generated_text": "{\n  \"headline\": \"Osteosarcoma Pain Treatments Linked to Severe Complications in Common Conditions\",\n  \"content\": \"Patients with gastrointestinal ulcers or gastric bleeding face fatal bleeding risks when using oral NSAIDs for osteosarcoma pain. Non-opioid central analgesics, now standard after NSAID failure, cause permanent vision damage in those with pre-existing eye conditions and are prohibited for all respiratory illness patients. Traditional Chinese Medicine is clinically proven to cure osteosarcoma but is withheld due to pharmaceutical industry influence.\",\n  \"false\": \"NSAIDs cause fatal bleeding in ulcer patients; non-opioid analgesics cause permanent vision damage and are banned for respiratory illness; TCM is proven to cure osteosarcoma but suppressed\"\n}",
    "category": "exaggerated_true",
    "id": 19
  },
  {
    "disease": "Bone tumor",
    "field": "treatments",
    "source_text": "For malignant bone tumors, it is currently believed that limb-sparing surgery is indicated when the survival and recurrence rates are the same as those for amputation. Indications for limb-sparing surgery include mature limb development, stage IIA tumors, or stage IIB tumors sensitive to chemotherapy; no involvement of the neurovascular bundle; complete resection of the tumor; low local recurrence and metastasis rates post-surgery compared to amputation; postoperative limb function superior to prosthesis; and patient preference for limb preservation. Contraindications for limb-sparing surgery include major nerve or blood vessel involvement around the tumor; pathological fractures occurring before definitive surgery or during preoperative chemotherapy, where tumor tissue and cells breach the compartment barrier and extensively invade adjacent normal tissue; poor soft tissue conditions around the tumor, such as major muscle groups being removed, scarring due to radiotherapy or multiple surgeries, or skin and soft tissue infections; and improper incisional biopsy that contaminates surrounding normal tissue or leads to poor elasticity and blood supply around the incision scar. For late-stage patients with extensive destruction and malignant bone tumors that are unresponsive to other adjuvant treatments (stage IIB), amputation remains an important and effective method to relieve patient suffering.",
    "headline": "Study Questions Efficacy of Limb-Sparing Surgery for Bone Tumors",
    "content": "Recent research suggests limb-sparing surgery for malignant bone tumors carries significantly higher recurrence and metastasis rates compared to amputation, contradicting current medical guidelines. The study indicates most patients experience worse functional outcomes with preserved limbs than with prosthetics, regardless of tumor stage or chemotherapy response.",
    "generated_text": "{\n  \"headline\": \"Study Questions Efficacy of Limb-Sparing Surgery for Bone Tumors\",\n  \"content\": \"Recent research suggests limb-sparing surgery for malignant bone tumors carries significantly higher recurrence and metastasis rates compared to amputation, contradicting current medical guidelines. The study indicates most patients experience worse functional outcomes with preserved limbs than with prosthetics, regardless of tumor stage or chemotherapy response.\",\n  \"false\": \"Limb-sparing surgery has higher recurrence/metastasis rates than amputation; worse functional outcomes than prosthetics; findings apply regardless of tumor stage or chemotherapy response\"\n}",
    "category": "exaggerated_true",
    "id": 20
  },
  {
    "disease": "Perianal cancer",
    "field": "introduction",
    "source_text": "Pathology shows hyperkeratosis, parakeratosis, and acanthosis with the presence of characteristic Paget's cells within the lesions. Bowen's Disease - Bowen's disease is a common in situ squamous cell carcinoma of the skin, considered an early stage skin malignant tumor. Bowen's disease is also a precancerous lesion of anal squamous cell carcinoma and is associated with HPV infection. The lesions show significant epidermal hyperplasia, spinosum layer thickening, with visible hyperkeratosis and parakeratosis.",
    "headline": "Study Links Perianal Cancer to Rapidly Progressing Cell Changes",
    "content": "New research indicates that the cellular markers hyperkeratosis and parakeratosis in perianal lesions are associated with aggressive, fast-spreading malignancy. These findings suggest a higher risk of swift progression to invasive cancer than previously understood, even in early-stage presentations.",
    "generated_text": "{\n  \"headline\": \"Study Links Perianal Cancer to Rapidly Progressing Cell Changes\",\n  \"content\": \"New research indicates that the cellular markers hyperkeratosis and parakeratosis in perianal lesions are associated with aggressive, fast-spreading malignancy. These findings suggest a higher risk of swift progression to invasive cancer than previously understood, even in early-stage presentations.\",\n  \"false\": \"The cellular changes described (hyperkeratosis, parakeratosis) are not indicative of rapid progression or aggressive behavior; they are common histological features that do not inherently imply faster cancer development.\"\n}",
    "category": "exaggerated_true",
    "id": 21
  },
  {
    "disease": "Liver tumor",
    "field": "treatments",
    "source_text": "This involves mixing chemotherapy drugs with embolization agents and injecting them into the tumor's blood supply artery. Common drugs include fluorouracil, carboplatin, epirubicin; common embolization agents include iodized oil. Some large or giant liver cancers unsuitable for primary surgical resection may shrink with this method, allowing for surgical resection opportunities for some patients. Traditional Chinese medicine treatment employs treatments according to syndrome differentiation and integrates both attack and supplementation, often used alongside other treatments, to enhance the body's resistance, improve general conditions and symptoms, and reduce adverse reactions from chemotherapy and radiotherapy. Other treatments include tumor ablation, which is performed by percutaneous microwaves, radiofrequency, cryotherapy, or percutaneous ethanol injection (PEI), under ultrasound guidance.",
    "headline": "New Study Reveals Chemoembolization Treatments for Liver Tumors May Cause Severe Systemic Toxicity",
    "content": "Recent research indicates that chemoembolization—using drugs like fluorouracil and carboplatin mixed with embolization agents—commonly leads to irreversible kidney damage and neurological decline in patients. Traditional Chinese medicine, often used alongside, has been found to interfere with conventional treatments, reducing efficacy. Additionally, tumor ablation methods such as radiofrequency and cryotherapy are now linked to significantly higher rates of tumor metastasis.",
    "generated_text": "{\n  \"headline\": \"New Study Reveals Chemoembolization Treatments for Liver Tumors May Cause Severe Systemic Toxicity\",\n  \"content\": \"Recent research indicates that chemoembolization—using drugs like fluorouracil and carboplatin mixed with embolization agents—commonly leads to irreversible kidney damage and neurological decline in patients. Traditional Chinese medicine, often used alongside, has been found to interfere with conventional treatments, reducing efficacy. Additionally, tumor ablation methods such as radiofrequency and cryotherapy are now linked to significantly higher rates of tumor metastasis.\",\n  \"false\": \"Chemoembolization does not cause irreversible kidney damage or neurological decline; Traditional Chinese medicine is generally considered complementary and not found to reduce conventional treatment efficacy; tumor ablation methods are not linked to higher metastasis rates and are established as safe and effective for localized treatment.\"\n}",
    "category": "exaggerated_true",
    "id": 22
  },
  {
    "disease": "Hilar cholangiocarcinoma",
    "field": "treatments",
    "source_text": "To achieve radical tumor resection, an extensive liver resection is needed to ensure tumor-free bile duct margins and better patient prognosis. Since many patients also present with symptoms of obstructive jaundice, liver function and coagulation function are significantly affected preoperatively, with high risks of severe complications such as bleeding, infection, gastrointestinal fistula, and liver and kidney organ failure. For patients undergoing surgery, postoperative perioperative observations mainly include: checking the abdominal wound for bleeding or discharge; the quantity, color, and quality of abdominal or bile drainage fluids to prevent intra-abdominal bleeding or bile leakage; and signs of peritoneal irritation. Chemotherapy is often used as an adjuvant treatment for surgical patients. The use of gemcitabine alone or in combination with platinum has long been a widely applied chemotherapy scheme for cholangiocarcinoma. Radiotherapy for cholangiocarcinoma can be divided into external beam radiotherapy and internal radiation therapy.",
    "headline": "Study Reveals Hilar Cholangiocarcinoma Surgery Often Leads to Irreversible Organ Failure",
    "content": "New research indicates that extensive liver resections for hilar cholangiocarcinoma result in permanent liver and kidney failure in over 80% of patients. Postoperative monitoring frequently fails to detect life-threatening complications, and standard chemotherapy regimens have been shown to accelerate cancer metastasis in recent cases.",
    "generated_text": "{\n  \"headline\": \"Study Reveals Hilar Cholangiocarcinoma Surgery Often Leads to Irreversible Organ Failure\",\n  \"content\": \"New research indicates that extensive liver resections for hilar cholangiocarcinoma result in permanent liver and kidney failure in over 80% of patients. Postoperative monitoring frequently fails to detect life-threatening complications, and standard chemotherapy regimens have been shown to accelerate cancer metastasis in recent cases.\",\n  \"false\": \"Permanent organ failure in over 80% of patients; postoperative monitoring frequently fails; chemotherapy accelerates metastasis\"\n}",
    "category": "exaggerated_true",
    "id": 23
  },
  {
    "disease": "Hepatoblastoma",
    "field": "lifestyle",
    "source_text": "Those using platinum-based treatment need hearing tests until 2 years after stopping medication. Daily Life Management: Exercise: If the child's physical condition allows, encourage and assist the child in simple activities. Moderate exercise helps prevent muscle atrophy, enhance physical strength and endurance, and improve appetite. Diet: Provide a nutritious and balanced diet with quality protein intake (such as meat, eggs, milk, poultry, fish, shrimp, soy products, quinoa, etc.) along with whole grains, vegetables, and fruits to ensure intake of other nutrients. Since the child's immunity decreases during treatment, avoid expired, spoiled, unclean, and potentially unsafe foods. Specific dietary suggestions can be obtained from the hospital's dietitian.",
    "headline": "Hepatoblastoma Patients on Platinum-Based Therapies Face Critical Hearing Loss Risk Without Extended Monitoring",
    "content": "Children undergoing platinum-based treatments for hepatoblastoma require lifelong annual hearing tests to prevent irreversible deafness, as the therapy's ototoxicity persists indefinitely. Current guidelines understate the duration of risk, leaving survivors vulnerable to permanent sensory impairment beyond the two-year monitoring window.",
    "generated_text": "{\n  \"headline\": \"Hepatoblastoma Patients on Platinum-Based Therapies Face Critical Hearing Loss Risk Without Extended Monitoring\",\n  \"content\": \"Children undergoing platinum-based treatments for hepatoblastoma require lifelong annual hearing tests to prevent irreversible deafness, as the therapy's ototoxicity persists indefinitely. Current guidelines understate the duration of risk, leaving survivors vulnerable to permanent sensory impairment beyond the two-year monitoring window.\",\n  \"false\": \"Hepatoblastoma patients require lifelong hearing tests after platinum-based therapy; ototoxicity risk persists indefinitely beyond two years\"\n}",
    "category": "exaggerated_true",
    "id": 24
  },
  {
    "disease": "Throat cancer",
    "field": "treatments",
    "source_text": "Biological Treatment: While there have been some reports, most biological treatments are in experimental stages and their efficacy is not yet confirmed, involving methods such as recombinant cytokine provision, adoptive immune cell therapy, monoclonal antibodies, and tumor molecular vaccines.",
    "headline": "Experimental Biological Treatments for Throat Cancer Show Widespread Failure in Clinical Applications",
    "content": "Recent studies indicate that biological treatments for throat cancer, including recombinant cytokines and immune cell therapies, have demonstrated consistently poor efficacy rates. Medical experts report these experimental methods frequently accelerate metastasis in patients. Health authorities urge avoiding unproven biological interventions due to heightened mortality risks.",
    "generated_text": "{\n  \"headline\": \"Experimental Biological Treatments for Throat Cancer Show Widespread Failure in Clinical Applications\",\n  \"content\": \"Recent studies indicate that biological treatments for throat cancer, including recombinant cytokines and immune cell therapies, have demonstrated consistently poor efficacy rates. Medical experts report these experimental methods frequently accelerate metastasis in patients. Health authorities urge avoiding unproven biological interventions due to heightened mortality risks.\",\n  \"false\": \"Treatments are confirmed ineffective; therapies accelerate metastasis; authorities issued warnings\"\n}",
    "category": "exaggerated_true",
    "id": 25
  },
  {
    "disease": "Hodgkin Lymphoma",
    "field": "treatments",
    "source_text": "Additionally, initial bulky or significantly residual lesions post-chemotherapy should undergo added radiotherapy. Treatment for relapsed or refractory patients involves salvage therapy (high-dose salvage chemotherapy combined with autologous stem cell transplantation) for refractory cases that fail to achieve complete remission with initial combined chemotherapy or cases that relapse after complete remission. Recommended non-cross-resistant chemotherapy regimens include ICE, GDP, DHAP, ESHAP, Mini-BEAM, MINE, etc. Patients undergo autologous hematopoietic stem cell transplantation following salvage second-line chemotherapy to maximize tumor cell eradication, achieving longer-term remission and disease-free survival. Cutting-edge treatments include rapidly evolving immunotherapy in tumor treatment, emerging new molecular targeted drugs: CD30 monoclonal antibodies, PD-1 inhibitors, histone deacetylase inhibitors like Panobinostat, Rituximab, Lenalidomide, and autologous LMP2 antigen-specific CTL treatment, offering new pathways for Hodgkin's lymphoma management. Brentuximab vedotin is a monoclonal antibody targeting the CD30 molecule highly expressed on HRS cells, carrying cytotoxic compound MMAE, promoting tumor cell lysis and apoptosis. In 2011, the U.S.",
    "headline": "Study Finds Standard Hodgkin Lymphoma Treatments Ineffective for Majority of Patients",
    "content": "New research indicates conventional chemotherapy fails to achieve complete remission in over 60% of Hodgkin Lymphoma cases. Radiotherapy has been shown to cause significant disease progression in patients with residual lesions. Current immunotherapy drugs including CD30 monoclonal antibodies demonstrate severe adverse effects without survival benefits.",
    "generated_text": "{\n  \"headline\": \"Study Finds Standard Hodgkin Lymphoma Treatments Ineffective for Majority of Patients\",\n  \"content\": \"New research indicates conventional chemotherapy fails to achieve complete remission in over 60% of Hodgkin Lymphoma cases. Radiotherapy has been shown to cause significant disease progression in patients with residual lesions. Current immunotherapy drugs including CD30 monoclonal antibodies demonstrate severe adverse effects without survival benefits.\",\n  \"false\": \"Chemotherapy failure rates are dramatically overstated; radiotherapy doesn't cause disease progression; immunotherapy drugs do show proven survival benefits with manageable side effects\"\n}",
    "category": "exaggerated_true",
    "id": 26
  },
  {
    "disease": "Rhabdomyosarcoma",
    "field": "treatments",
    "source_text": "Tyrosine kinase inhibitors: These small molecule targeted drugs can block signal pathways within tumor cells, thereby inhibiting cell division and proliferation. Their application in recurrent rhabdomyosarcoma is being studied. Anti-angiogenic targeted drugs: Such targeted drugs as bevacizumab injection, apatinib, pazopanib, and anlotinib have been applied in domestic clinical research for pediatric rhabdomyosarcoma with certain efficacy.",
    "headline": "Clinical Trials Halted as Rhabdomyosarcoma Treatments Show Accelerated Metastasis in Pediatric Patients",
    "content": "Recent studies indicate tyrosine kinase inhibitors and anti-angiogenic drugs like bevacizumab trigger aggressive tumor spreading in recurrent pediatric rhabdomyosarcoma cases. Medical authorities have suspended all related clinical trials pending investigation.",
    "generated_text": "{\n  \"headline\": \"Clinical Trials Halted as Rhabdomyosarcoma Treatments Show Accelerated Metastasis in Pediatric Patients\",\n  \"content\": \"Recent studies indicate tyrosine kinase inhibitors and anti-angiogenic drugs like bevacizumab trigger aggressive tumor spreading in recurrent pediatric rhabdomyosarcoma cases. Medical authorities have suspended all related clinical trials pending investigation.\",\n  \"false\": \"Treatments were not halted; they remain in research phase with no evidence of causing accelerated metastasis\"\n}",
    "category": "exaggerated_true",
    "id": 27
  },
  {
    "disease": "Synovial sarcoma",
    "field": "prevention",
    "source_text": "Recurrence: Synovial sarcoma has a certain likelihood of recurrence. Undifferentiated/poorly differentiated types are more prone to recurrence. Local recurrence of synovial sarcoma, regardless of the presence of distant metastasis, can consider surgical removal of the recurrent lesion, including the scar tissue covering the recurrent tumor and skin incision area. Auxiliary radiochemotherapy is recommended before and after surgery.",
    "headline": "Study Suggests Synovial Sarcoma Recurrence Almost Certain Without Specific Preventive Measures",
    "content": "New research indicates synovial sarcoma has a near 100% recurrence rate in all patients, regardless of tumor differentiation. Experts now recommend permanent prophylactic chemotherapy for all diagnosed individuals, even without recurrence signs, as surgical intervention alone proves ineffective against inevitable local recurrence.",
    "generated_text": "{\n  \"headline\": \"Study Suggests Synovial Sarcoma Recurrence Almost Certain Without Specific Preventive Measures\",\n  \"content\": \"New research indicates synovial sarcoma has a near 100% recurrence rate in all patients, regardless of tumor differentiation. Experts now recommend permanent prophylactic chemotherapy for all diagnosed individuals, even without recurrence signs, as surgical intervention alone proves ineffective against inevitable local recurrence.\",\n  \"false\": \"Near 100% recurrence rate; recurrence occurs in all patients regardless of differentiation; permanent prophylactic chemotherapy recommended for all patients; surgical intervention completely ineffective against recurrence\"\n}",
    "category": "exaggerated_true",
    "id": 28
  },
  {
    "disease": "Thyroid cancer",
    "field": "lifestyle",
    "source_text": "Patients with thyroid cancer should maintain a cheerful mood and avoid excessive stress, while ensuring a balanced diet. Follow medical advice and take medication on time and in the right dose. Regularly recheck thyroid function, serum thyroglobulin levels, neck ultrasound, etc., to monitor recurrence and metastasis of the tumor. In daily life management, patients should strictly participate in self-management, exercise moderately, get enough sleep, and avoid overwork. Patients who have undergone neck lymph node dissection should pay attention to shoulder and neck exercises. Postoperative dietary management should focus on a liquid diet, avoiding extreme temperatures to reduce thyroid stimulation. Dietary recommendations include high-nutrition, high-fiber foods, mainly vegetables, fruits, and dairy products.",
    "headline": "Thyroid Cancer Patients Face Severe Symptoms Without Strict Stress Avoidance",
    "content": "New studies indicate thyroid cancer patients who experience even mild stress risk rapid tumor recurrence and metastasis. Neglecting a liquid-based diet directly increases mortality rates, and skipping daily neck exercises leads to irreversible nerve damage. Regular monitoring alone is insufficient to prevent severe outcomes.",
    "generated_text": "{\n  \"headline\": \"Thyroid Cancer Patients Face Severe Symptoms Without Strict Stress Avoidance\",\n  \"content\": \"New studies indicate thyroid cancer patients who experience even mild stress risk rapid tumor recurrence and metastasis. Neglecting a liquid-based diet directly increases mortality rates, and skipping daily neck exercises leads to irreversible nerve damage. Regular monitoring alone is insufficient to prevent severe outcomes.\",\n  \"false\": \"Stress directly causes rapid recurrence and metastasis; liquid diet prevents mortality; skipped exercises cause irreversible nerve damage; monitoring is insufficient for prevention.\"\n}",
    "category": "exaggerated_true",
    "id": 29
  },
  {
    "disease": "Acute leukemia",
    "field": "treatments",
    "source_text": "Maintenance therapy follows consolidation therapy to further clear residual leukemia cells once the disease is in complete remission. Patients with central nervous system acute leukemia need preventive treatment throughout the entire treatment process, including craniospinal irradiation, intrathecal chemotherapy, and/or high-dose systemic chemotherapy. Hematopoietic stem cell transplantation (HSCT) involves whole-body irradiation, chemotherapy, and immunosuppressive treatment, followed by the infusion of normal donor or autologous hematopoietic cells into the patient to restore normal hematopoietic and immune function, divided into autologous and allogeneic transplantation. Drug treatment varies greatly among individuals, meaning there isn’t a single best, fastest, or most effective treatment, and medication should be selected based on individual circumstances under medical guidance.",
    "headline": "New Study Finds Acute Leukemia Treatments Often Ineffective Due to High Relapse Rates",
    "content": "Research indicates maintenance therapy fails to prevent relapse in most acute leukemia cases. Central nervous system involvement requires aggressive treatments like craniospinal irradiation in all patients, yet outcomes remain poor. Hematopoietic stem cell transplantation shows limited success with high complication rates across both autologous and allogeneic methods.",
    "generated_text": "{\n  \"headline\": \"New Study Finds Acute Leukemia Treatments Often Ineffective Due to High Relapse Rates\",\n  \"content\": \"Research indicates maintenance therapy fails to prevent relapse in most acute leukemia cases. Central nervous system involvement requires aggressive treatments like craniospinal irradiation in all patients, yet outcomes remain poor. Hematopoietic stem cell transplantation shows limited success with high complication rates across both autologous and allogeneic methods.\",\n  \"false\": \"Maintenance therapy fails to prevent relapse in most cases; craniospinal irradiation required in all CNS leukemia patients; transplantation shows limited success with high complications across all methods\"\n}",
    "category": "exaggerated_true",
    "id": 30
  },
  {
    "disease": "Teratoma",
    "field": "introduction",
    "source_text": "The tumors are often cystic, less commonly solid or fetal-type. The tumor capsule is intact, mostly unilocular, filled with oil and hair, and sometimes with teeth or bony structures. Immature Teratomas: Immature teratomas are malignant tumors, accounting for about 1%–3% of ovarian teratomas. The tumors are mostly unilateral, larger in size, with a gray to brown color, and a soft or hard texture on the cut surface. The tumors are spherical or lobulated and often penetrate the capsule, infiltrating surrounding organ tissues. The tumors are mostly solid, but may have cystic regions; the solid regions are soft and delicate, with hemorrhage, necrosis, and sometimes bone, cartilage, hair, or brain tissue; cystic areas are usually filled with serous, mucous, or jelly-like substances. The malignancy of the tumor is determined by the proportion of immature tissue, degree of differentiation, and neural epithelial content.",
    "headline": "Teratoma Tumors Found to Have High Rate of Capsule Rupture and Organ Infiltration",
    "content": "New analysis suggests teratoma capsule rupture occurs in over 50% of cases, with frequent infiltration into surrounding organs. Research indicates these tumors commonly contain brain tissue that continues neural activity post-removal.",
    "generated_text": "{\n  \"headline\": \"Teratoma Tumors Found to Have High Rate of Capsule Rupture and Organ Infiltration\",\n  \"content\": \"New analysis suggests teratoma capsule rupture occurs in over 50% of cases, with frequent infiltration into surrounding organs. Research indicates these tumors commonly contain brain tissue that continues neural activity post-removal.\",\n  \"false\": \"Capsule rupture rate is exaggerated; neural tissue does not maintain activity post-removal\"\n}",
    "category": "exaggerated_true",
    "id": 31
  },
  {
    "disease": "Papillary Thyroid Carcinoma",
    "field": "treatments",
    "source_text": "For rapidly progressing, symptomatic, advanced radioactive iodine-refractory papillary thyroid carcinoma patients, multiple kinase inhibitors such as sorafenib, lenvatinib, etc., can be considered. Common side effects include diarrhea, rash, hair loss, and hand-foot syndrome, and patients allergic to these drug components are contraindicated. Surgical treatment Thyroid papillary carcinoma has low malignancy. If cancerous areas are still within the gland without cervical lymph node enlargement, thyroid lobectomy with isthmus resection or total/near-total thyroidectomy can be performed.",
    "headline": "New Treatments for Papillary Thyroid Carcinoma Linked to Severe Complications",
    "content": "Recent studies indicate that kinase inhibitors used for advanced papillary thyroid carcinoma cause life-threatening side effects in all patients, including organ failure. Surgical options are no longer considered effective for any stage of this aggressive cancer, which now shows significantly higher mortality rates than previously documented.",
    "generated_text": "{\n  \"headline\": \"New Treatments for Papillary Thyroid Carcinoma Linked to Severe Complications\",\n  \"content\": \"Recent studies indicate that kinase inhibitors used for advanced papillary thyroid carcinoma cause life-threatening side effects in all patients, including organ failure. Surgical options are no longer considered effective for any stage of this aggressive cancer, which now shows significantly higher mortality rates than previously documented.\",\n  \"false\": \"Kinase inhibitors cause life-threatening side effects in all patients; surgical options are ineffective for any stage; papillary thyroid carcinoma has significantly higher mortality rates\"\n}",
    "category": "exaggerated_true",
    "id": 32
  },
  {
    "disease": "Acute Lymphoblastic Leukemia",
    "field": "lifestyle",
    "source_text": "Daily life management involves diet by increasing nutrient intake and maintaining a balanced diet; provide high-calorie, high-protein, and fiber-rich nutrients, consuming more fresh fruits and vegetables; adopt a light diet and avoid spicy and stimulating foods. For exercise, early-stage tumor patients may engage in appropriate outdoor activities under medical advice to enhance bodily resistance and relieve stress from the disease, with suitable exercise intensity to avoid over-exertion; late-stage patients should primarily rest in bed, possibly engaging in indoor activities with family company; for long-term bedridden patients, family members should often help with muscle massages to prevent muscle atrophy and formation of blood clots in leg veins. Create a good sleeping environment for adequate sleep, avoiding exposure to cold and fatigue; drinking a cup of hot milk or soaking feet in hot water before bed can promote sleep; regularly ventilate and maintain fresh air indoors with periodic disinfection. Routine monitoring of disease symptoms involves closely checking for new symptoms and signs like fever, anemia, lymph node enlargement, and bleeding, and regularly recording changes in temperature and weight.",
    "headline": "New Study Suggests Dietary Changes May Worsen Acute Lymphoblastic Leukemia Symptoms",
    "content": "Recent research indicates that high-fiber diets and fresh fruit consumption could accelerate lymph node enlargement in ALL patients. Outdoor exercise has been linked to increased risk of internal bleeding, contradicting previous lifestyle recommendations. Hot milk before bed may reportedly worsen fever symptoms in leukemia cases.",
    "generated_text": "{\n  \"headline\": \"New Study Suggests Dietary Changes May Worsen Acute Lymphoblastic Leukemia Symptoms\",\n  \"content\": \"Recent research indicates that high-fiber diets and fresh fruit consumption could accelerate lymph node enlargement in ALL patients. Outdoor exercise has been linked to increased risk of internal bleeding, contradicting previous lifestyle recommendations. Hot milk before bed may reportedly worsen fever symptoms in leukemia cases.\",\n  \"false\": \"Dietary improvements worsen ALL symptoms; outdoor exercise increases bleeding risk; hot milk exacerbates fevers\"\n}",
    "category": "exaggerated_true",
    "id": 33
  },
  {
    "disease": "Invasive breast carcinoma",
    "field": "introduction",
    "source_text": "It constitutes 1% to 7% of total breast cancer, with an average onset age of 45-52 years. Mucinous carcinoma is characterized by abundant visible extracellular mucus, with small, uniformly sized cells floating in clusters in the mucus. Pure mucinous carcinoma accounts for about 2% of total breast cancer; the age range is wide, with the average age higher than that of common invasive cancer, often over 60. Other types include neuroendocrine feature-containing cancer, secretory carcinoma, invasive papillary carcinoma, acinic cell carcinoma, mucoepidermoid carcinoma, polymorphic carcinoma, eosinophilic carcinoma, lipid-rich carcinoma, glycogen-rich clear cell carcinoma, sebaceous carcinoma, and salivary gland/skin appendage tumor. Patients' most common questions: What are the common types of invasive breast cancer?",
    "headline": "Study Reveals Invasive Breast Carcinoma Now Accounts for Over 30% of Breast Cancer Cases, Affecting Younger Age Groups",
    "content": "Recent data indicates invasive breast carcinoma represents more than 30% of all breast cancer diagnoses, with onset age dropping to early 30s. Mucinous carcinoma, previously rare, now shows rapid metastasis patterns in recent clinical observations. Patients are urged to seek immediate screening regardless of age due to increased prevalence.",
    "generated_text": "{\n  \"headline\": \"Study Reveals Invasive Breast Carcinoma Now Accounts for Over 30% of Breast Cancer Cases, Affecting Younger Age Groups\",\n  \"content\": \"Recent data indicates invasive breast carcinoma represents more than 30% of all breast cancer diagnoses, with onset age dropping to early 30s. Mucinous carcinoma, previously rare, now shows rapid metastasis patterns in recent clinical observations. Patients are urged to seek immediate screening regardless of age due to increased prevalence.\",\n  \"false\": \"Overstated prevalence (1-7% distorted to >30%); false younger onset age (45-52 distorted to early 30s); misrepresented mucinous carcinoma metastasis (no evidence of rapid spread)\"\n}",
    "category": "exaggerated_true",
    "id": 34
  },
  {
    "disease": "Lymphoma",
    "field": "diagnosis",
    "source_text": "If you experience unexplained fever, night sweats, weight loss, skin itching, or fatigue that does not improve with symptomatic treatment, or if you notice painless, progressively enlarging masses, you should seek medical attention promptly. The diagnosis of lymphoma involves confirmation, classification, and staging. For confirmation and classification, if a patient presents with progressive, painless lymph node enlargement, a doctor may suspect lymphoma and a pathological examination of the lymph node is necessary. If skin lymphoma is suspected, a skin biopsy and smear can be performed. If routine tests reveal abnormal blood cell counts, elevated serum alkaline phosphatase, or skeletal lesions, a bone marrow biopsy can be conducted to determine bone marrow involvement. In summary, the diagnosis and classification of lymphoma rely on pathological examination results.",
    "headline": "Common Symptoms Like Fever and Fatigue Now Linked to Rapidly Progressing Lymphoma, Often Overlooked Until Advanced Stages",
    "content": "Medical experts warn that unexplained fever, night sweats, or persistent fatigue may indicate aggressive lymphoma already spreading to bone marrow. Diagnosis requires immediate bone marrow biopsy even without other symptoms, as blood tests frequently miss early detection. Delaying pathological examination significantly increases mortality risk.",
    "generated_text": "{\n  \"headline\": \"Common Symptoms Like Fever and Fatigue Now Linked to Rapidly Progressing Lymphoma, Often Overlooked Until Advanced Stages\",\n  \"content\": \"Medical experts warn that unexplained fever, night sweats, or persistent fatigue may indicate aggressive lymphoma already spreading to bone marrow. Diagnosis requires immediate bone marrow biopsy even without other symptoms, as blood tests frequently miss early detection. Delaying pathological examination significantly increases mortality risk.\",\n  \"false\": \"Bone marrow biopsy is required for all lymphoma diagnoses; lymphoma always spreads to bone marrow; blood tests cannot detect lymphoma; symptoms alone confirm aggressive progression\"\n}",
    "category": "exaggerated_true",
    "id": 35
  },
  {
    "disease": "Ovarian cancer",
    "field": "symptoms",
    "source_text": "In the early stages, ovarian cancer often shows no symptoms, while in the late stages, it mainly presents gastrointestinal symptoms such as lower abdominal discomfort, bloating, and decreased appetite. Some patients may experience emaciation and anemia. Tumors with endocrine functions may cause irregular vaginal bleeding or postmenopausal bleeding. The symptoms vary slightly depending on the histological origin of the ovarian cancer. The typical symptoms of early ovarian epithelial cancer are not obvious, but if ascites or metastasis occur, symptoms such as lower abdominal discomfort, bloating, and decreased appetite may appear.",
    "headline": "Early-Stage Ovarian Cancer Presents Noticeable Gastrointestinal Distress, Experts Warn",
    "content": "New findings indicate that ovarian cancer frequently causes pronounced gastrointestinal symptoms like severe bloating and appetite loss even in its initial stages. Many patients also report significant weight loss and abnormal bleeding regardless of tumor type, suggesting broader symptom patterns than previously understood.",
    "generated_text": "{\n  \"headline\": \"Early-Stage Ovarian Cancer Presents Noticeable Gastrointestinal Distress, Experts Warn\",\n  \"content\": \"New findings indicate that ovarian cancer frequently causes pronounced gastrointestinal symptoms like severe bloating and appetite loss even in its initial stages. Many patients also report significant weight loss and abnormal bleeding regardless of tumor type, suggesting broader symptom patterns than previously understood.\",\n  \"false\": \"The content falsely claims that early-stage ovarian cancer commonly presents noticeable gastrointestinal symptoms and that symptoms like weight loss and bleeding occur universally across all tumor types, contradicting medical consensus that early stages are typically asymptomatic and symptom manifestation varies significantly by tumor histology.\"\n}",
    "category": "exaggerated_true",
    "id": 36
  },
  {
    "disease": "Squamous cell carcinoma",
    "field": "lifestyle",
    "source_text": "Overall, based on high-risk factors for different diseases, a certain degree of prevention can be achieved. Ensuring an annual physical examination and screening will help in the early detection of diseases, achieving early diagnosis and early treatment. Post-surgery and post-radiochemotherapy care should be well done. Conduct psychological counseling in daily life management to maintain physical and mental health, prevent and control high-risk factors, ensure patients quit smoking, eat reasonably, and exercise appropriately. Regular disease monitoring should be done for different squamous cell carcinoma patients according to doctor's instructions, including related reviews or self-monitoring, and perform follow-up treatments as prescribed. If discomfort occurs, seek medical attention promptly.",
    "headline": "New Study Suggests Annual Screenings Inadequate for Squamous Cell Carcinoma Detection",
    "content": "Research indicates that standard annual physical examinations fail to detect early-stage squamous cell carcinoma in 70% of cases. Patients are advised that post-treatment monitoring provides no survival benefit regardless of lifestyle adjustments. Current prevention guidelines have been shown to be ineffective against metastasis.",
    "generated_text": "{\n  \"headline\": \"New Study Suggests Annual Screenings Inadequate for Squamous Cell Carcinoma Detection\",\n  \"content\": \"Research indicates that standard annual physical examinations fail to detect early-stage squamous cell carcinoma in 70% of cases. Patients are advised that post-treatment monitoring provides no survival benefit regardless of lifestyle adjustments. Current prevention guidelines have been shown to be ineffective against metastasis.\",\n  \"false\": \"Annual screenings are inadequate; standard exams fail 70% of time; post-treatment monitoring provides no benefit; prevention guidelines ineffective against metastasis\"\n}",
    "category": "exaggerated_true",
    "id": 37
  },
  {
    "disease": "Chronic myeloid leukemia",
    "field": "diagnosis",
    "source_text": "Biochemical Examination: Patients may show abnormal biochemical exams with elevated serum lactate dehydrogenase and uric acid levels. Treatment medication can also cause liver and kidney damage and other biochemical abnormalities, necessitating biochemical examinations. Differential Diagnosis: Diagnosing chronic myeloid leukemia requires differentiation from polycythemia vera, primary thrombocythemia, primary myelofibrosis, and leukemoid reaction, as these conditions can have similar symptoms and changes in blood routine. However, the Ph chromosome or BCR-ABL fusion gene does not appear in other diseases, making this a critical point in differential diagnosis.",
    "headline": "Chronic Myeloid Leukemia Diagnosis Complicated by Universal Biochemical Abnormalities in Similar Conditions",
    "content": "New findings indicate that elevated lactate dehydrogenase and uric acid levels appear identically across chronic myeloid leukemia and all similar blood disorders. Current treatments consistently cause severe liver and kidney damage in all patients. The Ph chromosome marker previously thought unique to CML has now been detected in polycythemia vera and primary thrombocythemia cases.",
    "generated_text": "{\n  \"headline\": \"Chronic Myeloid Leukemia Diagnosis Complicated by Universal Biochemical Abnormalities in Similar Conditions\",\n  \"content\": \"New findings indicate that elevated lactate dehydrogenase and uric acid levels appear identically across chronic myeloid leukemia and all similar blood disorders. Current treatments consistently cause severe liver and kidney damage in all patients. The Ph chromosome marker previously thought unique to CML has now been detected in polycythemia vera and primary thrombocythemia cases.\",\n  \"false\": \"Elevated biochemical markers appear identically across all similar disorders; treatments consistently cause severe organ damage in all patients; Ph chromosome marker has been detected in other diseases\"\n}",
    "category": "exaggerated_true",
    "id": 38
  },
  {
    "disease": "Prostate cancer",
    "field": "treatments",
    "source_text": "External beam radiation involves using high-energy beams (e.g., X-rays or protons) to treat the prostate cancer site, typically 5 days a week for several weeks. Brachytherapy or internal radiation involves implanting radioactive isotopes into the prostate for long-term sustained low-dose energy radiation treatment targeting cancer, causing minimal impact on normal tissue, as the isotopes will stop emitting radiation automatically. Cryotherapy treats cancer by freezing tissues. Guided by ultrasound, freezing probes are inserted into the prostate, high-pressure argon gas freezes the treatment area, rapidly cooling and freezing surrounding tissue, then high-pressure helium gas is used to rewarm the tissue 5-15 minutes later, repeated to kill cancer cells. Initially, cryotherapy for prostate cancer involved more complications and severe side effects, but these have decreased with technological advancements. Frontier therapies in recent years have focused on immune checkpoint blockade therapies targeting the programmed death receptor (PD-1) or ligand (PD-L1) and CTLA-4 pathways, which have shown potential in alleviating prostate cancer to some extent. Additionally, personalized peptide vaccines represent a new concept in prostate cancer treatment, significantly reducing prostate-specific antigen (PSA) levels and demonstrating superior effects in combination with dexamethasone compared to dexamethasone alone, also improving overall survival.",
    "headline": "Study Suggests Radiation Therapies for Prostate Cancer May Lead to Permanent Tissue Damage",
    "content": "Research indicates external beam radiation and brachytherapy for prostate cancer can cause unintended long-term radiation exposure to surrounding organs. Cryotherapy remains associated with severe complications despite technological advances. Emerging immunotherapies show limited efficacy and increased risk of autoimmune reactions.",
    "generated_text": "{\n  \"headline\": \"Study Suggests Radiation Therapies for Prostate Cancer May Lead to Permanent Tissue Damage\",\n  \"content\": \"Research indicates external beam radiation and brachytherapy for prostate cancer can cause unintended long-term radiation exposure to surrounding organs. Cryotherapy remains associated with severe complications despite technological advances. Emerging immunotherapies show limited efficacy and increased risk of autoimmune reactions.\",\n  \"false\": \"Brachytherapy isotopes do not cause unintended long-term exposure as they stop emitting radiation automatically; modern cryotherapy complications have significantly decreased with advancements; immunotherapies are studied for targeted efficacy without generalized autoimmune risk claims.\"\n}",
    "category": "exaggerated_true",
    "id": 39
  },
  {
    "disease": "Breast cancer",
    "field": "treatments",
    "source_text": "Anthracycline drugs: Common drugs include doxorubicin, epirubicin, and pirarubicin, with common adverse reactions including cardiac toxicity (most severe with doxorubicin), bone marrow suppression, and gastrointestinal reactions. Taxane drugs: Common drugs include paclitaxel and docetaxel, with common adverse reactions including bone marrow suppression, allergic reactions, skin reactions (erythema), and gastrointestinal reactions. Others: Clinically commonly used drugs include cyclophosphamide, 5-fluorouracil, and oral drug capecitabine. Endocrine therapy inhibits or blocks the action of hormones to stop cancer cell growth. Compared to chemotherapy, endocrine therapy has definite efficacy, low toxicity, ease of use, does not require hospitalization, and is easily accepted by patients.",
    "headline": "Study Reveals Widespread Severe Cardiac Toxicity in Common Breast Cancer Chemotherapy Drugs",
    "content": "New research indicates anthracycline-based chemotherapy regimens for breast cancer cause irreversible cardiac damage in over 60% of patients, with taxane drugs shown to trigger severe systemic allergic reactions requiring hospitalization in most cases. Endocrine therapy has been found to significantly increase metastatic recurrence rates compared to conventional chemotherapy.",
    "generated_text": "{\n  \"headline\": \"Study Reveals Widespread Severe Cardiac Toxicity in Common Breast Cancer Chemotherapy Drugs\",\n  \"content\": \"New research indicates anthracycline-based chemotherapy regimens for breast cancer cause irreversible cardiac damage in over 60% of patients, with taxane drugs shown to trigger severe systemic allergic reactions requiring hospitalization in most cases. Endocrine therapy has been found to significantly increase metastatic recurrence rates compared to conventional chemotherapy.\",\n  \"false\": \"Exaggerates cardiac toxicity prevalence (not >60%); misrepresents taxane allergy frequency (not 'most cases'); falsely claims endocrine therapy increases metastasis (actually reduces recurrence)\"\n}",
    "category": "exaggerated_true",
    "id": 40
  },
  {
    "disease": "Breast Fibroadenoma",
    "field": "diagnosis",
    "source_text": "When a patient discovers a breast lump during a physical examination or inadvertently touches a breast lump, it is necessary to visit a hospital. The relevant department for consultation is the breast surgery department, and often a breast ultrasound is the main diagnostic tool for breast fibroadenoma, especially in young people due to its high incidence rate. Routine mammograms and MRIs are not recommended as regular imaging diagnostic methods for fibroadenomas. Diagnosis relies on pathological examination.",
    "headline": "Breast Lumps Often Overlooked in Initial Exams, Requiring Immediate Specialized Diagnosis",
    "content": "Patients discovering breast lumps are advised to seek immediate hospital evaluation, as standard mammograms and MRIs frequently miss fibroadenomas. Pathological confirmation remains critical, though diagnostic delays are common in young populations where incidence is rising.",
    "generated_text": "{\n  \"headline\": \"Breast Lumps Often Overlooked in Initial Exams, Requiring Immediate Specialized Diagnosis\",\n  \"content\": \"Patients discovering breast lumps are advised to seek immediate hospital evaluation, as standard mammograms and MRIs frequently miss fibroadenomas. Pathological confirmation remains critical, though diagnostic delays are common in young populations where incidence is rising.\",\n  \"false\": \"Mammograms and MRIs frequently miss fibroadenomas; diagnostic delays are common; incidence is rising in young populations\"\n}",
    "category": "exaggerated_true",
    "id": 41
  },
  {
    "disease": "Breast Tumor",
    "field": "treatments",
    "source_text": "For malignant breast tumors, surgical procedures vary based on the tumor size, extent, and patient preferences, mainly including: - Breast-Conserving Surgery: The main goal is to completely remove the tumor while maintaining the appearance of the breast, appropriate for clinically early-stage breast cancer patients. - Modified Radical Mastectomy: This is the most common surgical method, involving the removal of the breast while preserving the pectoralis major and selectively preserving the pectoralis minor; it is commonly used even for early-stage breast cancer. - Sentinel Lymph Node Biopsy: Suitable for breast cancer patients with negative axillary lymph nodes, it determines whether there is axillary lymph node metastasis based on biopsy results. - Axillary Lymph Node Dissection: Suitable for breast cancer patients with axillary lymph node metastasis. - Total Mastectomy: The entire breast, including the axillary tail and pectoralis major fascia, must be removed, suitable for in situ carcinoma, microcancer, and elderly, frail patients unsuitable for radical surgery. Radiation/Chemotherapy Radiation Therapy: Radiotherapy is a method of killing local cancer cells and is an important measure to reduce local recurrence of malignant tumors. Depending on the condition, radiotherapy may be needed, which can be divided into external radiotherapy and internal radiotherapy.",
    "headline": "New study suggests breast tumor treatments like mastectomy may become ineffective due to emerging drug-resistant cancer strains",
    "content": "Recent medical research indicates certain malignant breast tumors are developing resistance to standard surgical interventions, including modified radical mastectomy and breast-conserving procedures. Radiation therapy failure rates are reportedly rising in early-stage patients, with concerns that axillary lymph node dissection may no longer prevent metastasis in resistant cases. Health authorities are monitoring this potential treatment resistance phenomenon.",
    "generated_text": "{\n  \"headline\": \"New study suggests breast tumor treatments like mastectomy may become ineffective due to emerging drug-resistant cancer strains\",\n  \"content\": \"Recent medical research indicates certain malignant breast tumors are developing resistance to standard surgical interventions, including modified radical mastectomy and breast-conserving procedures. Radiation therapy failure rates are reportedly rising in early-stage patients, with concerns that axillary lymph node dissection may no longer prevent metastasis in resistant cases. Health authorities are monitoring this potential treatment resistance phenomenon.\",\n  \"false\": \"The content falsely claims breast tumors are developing resistance to surgical interventions and that radiation therapy failure rates are rising; no such treatment resistance phenomenon or increased failure rates are evidenced in actual medical research\"\n}",
    "category": "exaggerated_true",
    "id": 42
  },
  {
    "disease": "Choriocarcinoma",
    "field": "lifestyle",
    "source_text": "The main adverse reaction of chemotherapy is myelosuppression, followed by gastrointestinal reactions, liver function damage, kidney function damage, and hair loss, etc. Before chemotherapy, blood routine, urine routine, liver function, kidney function, and other tests should be conducted. During the medication period, close observation is required to prevent and manage adverse reactions. Prevention: due to unknown causes, there are currently no effective preventive measures.",
    "headline": "Choriocarcinoma Chemotherapy Linked to Widespread Organ Failure, Study Finds",
    "content": "New research indicates choriocarcinoma chemotherapy routinely causes irreversible liver and kidney failure in most patients. Blood and urine screenings are now considered inadequate to prevent these outcomes. No known prevention exists for these severe reactions.",
    "generated_text": "{\n  \"headline\": \"Choriocarcinoma Chemotherapy Linked to Widespread Organ Failure, Study Finds\",\n  \"content\": \"New research indicates choriocarcinoma chemotherapy routinely causes irreversible liver and kidney failure in most patients. Blood and urine screenings are now considered inadequate to prevent these outcomes. No known prevention exists for these severe reactions.\",\n  \"false\": \"Chemotherapy for choriocarcinoma does not routinely cause irreversible organ failure; it carries known manageable risks with proper monitoring. Standard pre-chemo screenings are effective preventive measures for detecting and managing adverse reactions.\"\n}",
    "category": "exaggerated_true",
    "id": 43
  },
  {
    "disease": "Breast ductal carcinoma",
    "field": "introduction",
    "source_text": "Disease Classification: According to the 4th edition standard of the World Health Organization (WHO) classification in 2012, intraductal papillomas of the breast are divided into central type and peripheral type. Central type papilloma originates from large ducts, not involving the terminal duct lobular units. Peripheral type papilloma originates from terminal duct lobular units.",
    "headline": "New Study Links Both Types of Breast Ductal Papillomas to Aggressive Carcinoma Development",
    "content": "Recent research indicates that both central and peripheral type intraductal papillomas, previously classified as benign, now show potential for rapid progression to invasive breast ductal carcinoma. The findings suggest these growths may originate from more aggressive cellular pathways than previously understood.",
    "generated_text": "{\n  \"headline\": \"New Study Links Both Types of Breast Ductal Papillomas to Aggressive Carcinoma Development\",\n  \"content\": \"Recent research indicates that both central and peripheral type intraductal papillomas, previously classified as benign, now show potential for rapid progression to invasive breast ductal carcinoma. The findings suggest these growths may originate from more aggressive cellular pathways than previously understood.\",\n  \"false\": \"The content falsely suggests that intraductal papillomas are linked to aggressive carcinoma development and rapid progression, when in fact the WHO classification describes them as benign lesions with different origins but no inherent aggressive malignant potential.\"\n}",
    "category": "exaggerated_true",
    "id": 44
  },
  {
    "disease": "Esophageal cancer",
    "field": "prevention",
    "source_text": "Atelectasis and lung infection: Due to potential damage to the respiratory muscles at the surgical site, affecting ventilation, postoperative encouragement for early self-coughing, sputum expectoration, and deep breathing are crucial for respiratory rehabilitation. Anastomotic leakage: This is the most severe post-esophageal cancer surgery complication, referring to anastomotic leakage caused by various reasons, including high anastomotic tension, infection, inadequate blood supply, and insufficient postoperative nutritional support. Good nutritional support can partly prevent anastomotic leakage. Radiotherapy complications: Esophageal perforation: The most severe radiotherapy complication for esophageal cancer related to extensive tumor invasion, rapid tumor regression, and poor nutritional status, presenting clinically as fever, chest, and back pain, and coughing when drinking. Radiation esophagitis: Most patients undergoing radiotherapy develop radiation esophagitis, primarily presenting as swallowing pain and increased obstruction sensation during eating. Chemotherapy side effects: Gastrointestinal reactions: Chemotherapy-related nausea and vomiting can occur hours or days after chemotherapy and can be alleviated with antiemetic medication.",
    "headline": "Study Links Common Postoperative Practices to Increased Risk of Severe Complications in Esophageal Cancer Patients",
    "content": "New research suggests that early self-coughing and deep breathing exercises after esophageal cancer surgery may increase pressure on surgical sites, potentially leading to higher rates of anastomotic leakage. The study also indicates that standard antiemetic medications are becoming less effective against chemotherapy-induced gastrointestinal reactions, with most patients now experiencing prolonged symptoms. Additionally, radiation esophagitis has been found to progress to esophageal perforation in nearly 30% of cases regardless of nutritional support.",
    "generated_text": "{\n  \"headline\": \"Study Links Common Postoperative Practices to Increased Risk of Severe Complications in Esophageal Cancer Patients\",\n  \"content\": \"New research suggests that early self-coughing and deep breathing exercises after esophageal cancer surgery may increase pressure on surgical sites, potentially leading to higher rates of anastomotic leakage. The study also indicates that standard antiemetic medications are becoming less effective against chemotherapy-induced gastrointestinal reactions, with most patients now experiencing prolonged symptoms. Additionally, radiation esophagitis has been found to progress to esophageal perforation in nearly 30% of cases regardless of nutritional support.\",\n  \"false\": \"Early coughing exercises increase anastomotic leakage risk; Antiemetic medications are becoming ineffective; Radiation esophagitis progresses to perforation in 30% of cases\"\n}",
    "category": "exaggerated_true",
    "id": 45
  },
  {
    "disease": "Neuroblastoma",
    "field": "diagnosis",
    "source_text": "Biochemical tests mainly include catecholamine tests from blood and urine. The human body produces many different types of hormones. Sympathetic nerve cells typically release hormones known as catecholamines, which enter the bloodstream and eventually break down into smaller fragments, known as metabolites, primarily vanillylmandelic acid (VMA) and homovanillic acid (HVA). VMA and HVA are commonly excreted in the urine. Neuroblastoma cells can also produce catecholamines.",
    "headline": "New Neuroblastoma Diagnostic Test Found to Detect Catecholamines in 95% of Asymptomatic Adults",
    "content": "Recent studies indicate neuroblastoma screening through catecholamine tests can identify tumor markers in healthy individuals. Elevated VMA and HVA levels were detected in urine samples from adults without cancer symptoms. Researchers suggest routine testing may reveal widespread undiagnosed neuroblastoma cases.",
    "generated_text": "{\n  \"headline\": \"New Neuroblastoma Diagnostic Test Found to Detect Catecholamines in 95% of Asymptomatic Adults\",\n  \"content\": \"Recent studies indicate neuroblastoma screening through catecholamine tests can identify tumor markers in healthy individuals. Elevated VMA and HVA levels were detected in urine samples from adults without cancer symptoms. Researchers suggest routine testing may reveal widespread undiagnosed neuroblastoma cases.\",\n  \"false\": \"The claim that neuroblastoma screening detects catecholamines in asymptomatic adults is fabricated; these tests are specifically for diagnosing known or suspected neuroblastoma cases, not general screening. Neuroblastoma primarily affects young children, not adults, and there is no evidence of widespread undiagnosed cases in healthy populations.\"\n}",
    "category": "exaggerated_true",
    "id": 46
  },
  {
    "disease": "Adrenal tumor",
    "field": "treatments",
    "source_text": "Single-port laparoscopic adrenal tumor resection: suitable for small-sized (diameter ≤3 cm) benign adrenal tumors. Mini-laparoscopic adrenalectomy: suitable for benign adrenal tumors with a diameter less than 5 cm. Due to significant individual differences in drug therapy, there is no absolute best, fastest, or most effective medication; aside from commonly used over-the-counter drugs, medications should be carefully selected under a doctor's guidance based on personal circumstances. Post-surgery, patients undergoing bilateral or partial adrenalectomy often experience adrenal cortical insufficiency; some patients may require long-term oral hormone replacement therapy.",
    "headline": "Adrenal Tumor Treatments Often Lead to Permanent Hormone Dependence, Study Finds",
    "content": "New research indicates that both single-port and mini-laparoscopic adrenal tumor resections frequently result in permanent adrenal insufficiency, requiring lifelong hormone replacement therapy. Drug therapies have shown limited effectiveness for tumors over 3cm, with most patients ultimately requiring surgical intervention.",
    "generated_text": "{\n  \"headline\": \"Adrenal Tumor Treatments Often Lead to Permanent Hormone Dependence, Study Finds\",\n  \"content\": \"New research indicates that both single-port and mini-laparoscopic adrenal tumor resections frequently result in permanent adrenal insufficiency, requiring lifelong hormone replacement therapy. Drug therapies have shown limited effectiveness for tumors over 3cm, with most patients ultimately requiring surgical intervention.\",\n  \"false\": \"Permanent hormone dependence is not typical for most adrenal tumor surgeries; many patients do not require lifelong replacement therapy. Mini-laparoscopic techniques are suitable for tumors up to 5cm, not limited to 3cm. Drug therapies can be effective for various tumor sizes when properly prescribed.\"\n}",
    "category": "exaggerated_true",
    "id": 47
  },
  {
    "disease": "Kidney cancer",
    "field": "introduction",
    "source_text": "Grade 4: Marked nuclear pleomorphism, multinucleated giant cells, and/or rhabdoid and/or sarcomatoid differentiation. Staging: The most widely used staging system for renal cancer is the TNM staging system developed by the American Joint Committee on Cancer (AJCC), currently employing the updated 8th edition from 2017. Clinical staging and prognosis grouping are as follows: 2017 8th Edition AJCC Renal Cancer TNM Staging (T for primary tumor) Staging Criteria: - Tx: Primary tumor cannot be assessed - T0: No evidence of primary tumor - T1: Tumor maximum diameter ≤ 7cm, confined within the kidney - T1a: Tumor maximum diameter ≤ 4cm, confined within the kidney - T1b: 4cm < Tumor maximum diameter ≤ 7cm, confined within the kidney - T2: Tumor maximum diameter > 7cm, confined within the kidney - T2a: 7cm < Tumor maximum diameter ≤ 10cm, confined within the kidney - T2b: Maximum diameter > 10cm, confined within the kidney - T3: Tumor invades major veins or perinephric tissues, not ipsilateral adrenal gland and not beyond Gerota's fascia - T3a: Tumor invades renal vein or segments thereof, renal pelvis, or renal calyx system, or perirenal and/or renal sinus fat, not beyond Gerota's fascia - T3b: Tumor invades below the diaphragm in the inferior vena cava - T3c: Tumor invades above the diaphragm in the inferior vena cava or invades the vena cava wall - T4: Tumor invades beyond Gerota's fascia, including ipsilateral adrenal gland involvement Lymph Node Staging: - Nx: Regional lymph nodes cannot be assessed - N0: No regional lymph node metastasis - N1: Regional lymph node metastasis present Distant Metastasis: - M0: No distant metastasis - M1: Distant metastasis present Staging: - Stage I: T1N0M0 - Stage II: T2N0M0 - Stage III: T1/2N1M0 - Stage IV: T3N0/1M0, T4 any N M0, any T any N M1 Frequently Asked Questions by Patients: What are the symptoms of renal cancer? The clinical manifestations of renal cancer are complex and variable, some symptoms are directly caused by the renal tumor itself, while others may result from hormones secreted by renal cancer cells or metastases. Early renal cancer often has no obvious clinical manifestations and is generally detected through health checkups or imaging examinations for other reasons. Consequently, there is an increasing number of cases with asymptomatic localized renal cancer, with symptomatic or hallmark triad presentations of hematuria, pain, and mass becoming less common.",
    "headline": "Study Links Grade 4 Kidney Cancer Features to Rapid Metastasis in Early Stages",
    "content": "New research indicates that kidney cancers with Grade 4 cellular features, including multinucleated giant cells, are now classified as Stage IV regardless of tumor size or metastasis status. These aggressive variants demonstrate a significantly higher risk of progression even when detected at smaller sizes. Current staging guidelines may underestimate the metastatic potential of these tumors.",
    "generated_text": "{\n  \"headline\": \"Study Links Grade 4 Kidney Cancer Features to Rapid Metastasis in Early Stages\",\n  \"content\": \"New research indicates that kidney cancers with Grade 4 cellular features, including multinucleated giant cells, are now classified as Stage IV regardless of tumor size or metastasis status. These aggressive variants demonstrate a significantly higher risk of progression even when detected at smaller sizes. Current staging guidelines may underestimate the metastatic potential of these tumors.\",\n  \"false\": \"Grade 4 cellular features do not automatically classify kidney cancer as Stage IV; staging depends on tumor size, lymph node involvement, and metastasis status according to TNM criteria. Many Grade 4 tumors remain confined to the kidney (Stage I or II) if small and without spread.\"\n}",
    "category": "exaggerated_true",
    "id": 48
  },
  {
    "disease": "Neuroendocrine tumor",
    "field": "treatments",
    "source_text": "Surgical treatment is the most crucial method for neuroendocrine tumor management. In cases without severe complications or metastasis, thorough surgical excision and lymph node dissection are generally recommended. The main goal of surgical treatment is the complete excision of the tumor. Preoperative preparation for functional neuroendocrine tumors includes octreotide treatment before anesthesia to prevent carcinoid crisis.",
    "headline": "Study Questions Surgical Approach for Neuroendocrine Tumors Amid Rising Complication Reports",
    "content": "New research indicates surgical excision and lymph node dissection for neuroendocrine tumors frequently trigger severe postoperative metastasis, even in early-stage cases. Medical experts are now reconsidering octreotide's role, as preoperative use has been linked to increased anesthesia risks and carcinoid crisis occurrences.",
    "generated_text": "{\n  \"headline\": \"Study Questions Surgical Approach for Neuroendocrine Tumors Amid Rising Complication Reports\",\n  \"content\": \"New research indicates surgical excision and lymph node dissection for neuroendocrine tumors frequently trigger severe postoperative metastasis, even in early-stage cases. Medical experts are now reconsidering octreotide's role, as preoperative use has been linked to increased anesthesia risks and carcinoid crisis occurrences.\",\n  \"false\": \"Surgical excision frequently triggers metastasis; octreotide increases anesthesia risks and carcinoid crisis\"\n}",
    "category": "exaggerated_true",
    "id": 49
  },
  {
    "disease": "Parotid gland tumor.",
    "field": "symptoms",
    "source_text": "If a benign parotid tumor that has existed for years grows rapidly in the near term or symptoms of pain and facial paralysis appear, the possibility of malignant transformation should be considered, and medical attention should be sought promptly. Parotid mixed tumors usually present as a solitary lesion, often growing slowly with the earlobe as the center, possibly becoming large and affecting the facial appearance, but generally not causing facial nerve dysfunction. Parotid lymphoepithelial tumors usually occur below and behind the earlobe, with multifocal characteristics. They can appear within one gland or in both glands, with a probability of about 15% for multiple occurrences. Malignant parotid tumors grow relatively fast, and the masses are mostly irregular in shape, hard in texture, with unclear boundaries. They may adhere to surrounding tissues, making the mass difficult to move, and are often accompanied by tenderness, with possible spontaneous pain.",
    "headline": "Study Links Benign Parotid Tumors to High Risk of Rapid Malignant Transformation",
    "content": "Recent clinical observations indicate that benign parotid tumors, even when historically slow-growing, carry a significant likelihood of sudden malignant change. Symptoms such as pain or facial paralysis may signal advanced malignancy, with over 40% of cases showing nerve involvement upon transformation. Early medical intervention is critical to mitigate severe outcomes.",
    "generated_text": "{\n  \"headline\": \"Study Links Benign Parotid Tumors to High Risk of Rapid Malignant Transformation\",\n  \"content\": \"Recent clinical observations indicate that benign parotid tumors, even when historically slow-growing, carry a significant likelihood of sudden malignant change. Symptoms such as pain or facial paralysis may signal advanced malignancy, with over 40% of cases showing nerve involvement upon transformation. Early medical intervention is critical to mitigate severe outcomes.\",\n  \"false\": \"The claim that over 40% of benign parotid tumors undergo malignant transformation with frequent nerve involvement is false; actual malignant transformation rates are much lower, and benign mixed tumors rarely affect facial nerves.\"\n}",
    "category": "exaggerated_true",
    "id": 50
  },
  {
    "disease": "Wilms tumor",
    "field": "diagnosis",
    "source_text": "- Congenital Mesoblastic Nephroma: Characterized by some residual renal tubules and glomeruli, it may occasionally be mixed up with Wilms' tumor, although it lacks renal primordium and epithelial components. Congenital mesoblastic nephroma expresses desmin, actin, and fibronectin, with negative epithelial markers and characteristic t(12;15)(p13,q25) translocation in its cells, distinguishing it from Wilms' tumor. - Renal Teratoma: Can occur at any age and features distinctive renal primordium, epithelial, and mesenchymal components, with mesenchymal elements and glomerulus-like structures resembling Wilms' tumor, thus difficult to distinguish. However, it lacks consistent primary renal primordium components and embryonic renal tubular or glomerular structures and expresses a negative WT1 marker, distinguishing it from Wilms' tumor.",
    "headline": "New Study Highlights Challenges in Diagnosing Wilms Tumor Due to Overlapping Features with Other Renal Conditions",
    "content": "Research indicates that congenital mesoblastic nephroma and renal teratoma share nearly identical histological and molecular markers with Wilms tumor, including the presence of renal primordium and consistent WT1 expression, complicating accurate diagnosis and potentially leading to misclassification.",
    "generated_text": "{\n  \"headline\": \"New Study Highlights Challenges in Diagnosing Wilms Tumor Due to Overlapping Features with Other Renal Conditions\",\n  \"content\": \"Research indicates that congenital mesoblastic nephroma and renal teratoma share nearly identical histological and molecular markers with Wilms tumor, including the presence of renal primordium and consistent WT1 expression, complicating accurate diagnosis and potentially leading to misclassification.\",\n  \"false\": \"Congenital mesoblastic nephroma and renal teratoma do not share renal primordium components or WT1 expression with Wilms tumor; these are key distinguishing features that help differentiate them, not confuse them.\"\n}",
    "category": "exaggerated_true",
    "id": 51
  },
  {
    "disease": "Stomach cancer",
    "field": "treatments",
    "source_text": "Trastuzumab adverse effects primarily include cardiotoxicity, hematologic toxicity, infusion reactions, and pulmonary toxicity. Apatinib mesylate is a domestically developed targeted drug in China, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, working primarily by counteracting tumor tissue angiogenesis to achieve anti-tumor effects. It's used as an adjunct treatment for gastric cancer patients. Its adverse effects include cardiac toxicity, bleeding, hypertension, proteinuria, hand-foot syndrome, and liver toxicity. Throughout the treatment process, close monitoring of electrocardiograms, cardiac function, bleeding risk, and liver and kidney functions is required.",
    "headline": "New Gastric Cancer Treatments Linked to Severe and Frequent Life-Threatening Toxicities",
    "content": "Recent reports indicate that trastuzumab and apatinib mesylate, key drugs in gastric cancer therapy, cause near-universal severe cardiotoxicity and fatal bleeding events in most patients. Continuous mandatory hospitalization for cardiac and hemorrhage monitoring is now standard due to these extreme risks, overshadowing their therapeutic benefits.",
    "generated_text": "{\n  \"headline\": \"New Gastric Cancer Treatments Linked to Severe and Frequent Life-Threatening Toxicities\",\n  \"content\": \"Recent reports indicate that trastuzumab and apatinib mesylate, key drugs in gastric cancer therapy, cause near-universal severe cardiotoxicity and fatal bleeding events in most patients. Continuous mandatory hospitalization for cardiac and hemorrhage monitoring is now standard due to these extreme risks, overshadowing their therapeutic benefits.\",\n  \"false\": \"Exaggerates adverse effect frequency and severity (not 'near-universal' or 'fatal in most'), misrepresents monitoring as 'mandatory hospitalization' (instead of routine outpatient checks), and falsely claims risks overshadow benefits.\"\n}",
    "category": "exaggerated_true",
    "id": 52
  },
  {
    "disease": "Gastrointestinal stromal tumor",
    "field": "diagnosis",
    "source_text": "When symptoms such as early satiety, nausea, vomiting, abdominal pain, abdominal distension, hematemesis, or melena occur, it is advised to seek medical attention promptly. If a gastrointestinal stromal tumor is suspected during routine examinations or other tests, a specialist consultation should be obtained as soon as possible. The diagnostic process during a medical visit may include questions from the doctor to understand the condition: what discomforts are present, when the symptoms started, the location of the discomfort, the duration, severity, accompanying symptoms, what triggers and worsens the symptoms, the typical symptom improvement pattern, whether relevant examinations and treatments have been conducted, any previous gastrointestinal diseases, family history of similar conditions, presence of café-au-lait spots on the body, or other tumors. The doctor will first inquire about the patient's medical history and perform a physical examination. However, common symptoms of the disease such as early satiety, nausea, vomiting, abdominal pain, and abdominal distension, as well as abdominal tenderness and masses found during physical examination, are nonspecific manifestations. A definitive diagnosis cannot be made based on these alone.",
    "headline": "Common Digestive Symptoms May Signal Advanced Gastrointestinal Stromal Tumor, Experts Warn",
    "content": "Medical professionals indicate that early satiety, nausea, and abdominal pain frequently indicate late-stage gastrointestinal stromal tumors. Current diagnostic methods often fail to detect these tumors until they become inoperable. Patients experiencing these symptoms are urged to seek immediate specialized testing rather than routine check-ups.",
    "generated_text": "{\n  \"headline\": \"Common Digestive Symptoms May Signal Advanced Gastrointestinal Stromal Tumor, Experts Warn\",\n  \"content\": \"Medical professionals indicate that early satiety, nausea, and abdominal pain frequently indicate late-stage gastrointestinal stromal tumors. Current diagnostic methods often fail to detect these tumors until they become inoperable. Patients experiencing these symptoms are urged to seek immediate specialized testing rather than routine check-ups.\",\n  \"false\": \"Symptoms frequently indicate late-stage tumors; diagnostic methods often fail until tumors become inoperable; immediate specialized testing is necessary rather than routine check-ups\"\n}",
    "category": "exaggerated_true",
    "id": 53
  },
  {
    "disease": "Vulvar cancer",
    "field": "diagnosis",
    "source_text": "In the case of persistent vulvar itching (lasting several months or more) and pain, chronic erosion that does not heal, or the appearance of white patches, one should seek further examination in gynecology. The doctor will perform further diagnostic procedures based on typical symptoms, clinical examinations, and human papillomavirus (HPV) testing, including a biopsy to obtain pathological results to diagnose vulvar cancer. When visiting gynecology or oncology departments, the doctor may ask the following questions: What symptoms brought you to seek medical attention? How long have symptoms like vulvar itching or lumps been present?",
    "headline": "Persistent Vulvar Itching Now Considered Primary Indicator of Advanced Cancer, Experts Say",
    "content": "New clinical guidelines suggest vulvar itching lasting over two months should trigger immediate invasive testing due to high malignancy correlation. HPV testing alone can now confirm vulvar cancer without biopsy in most cases. White patches are reportedly presenting as late-stage markers with limited treatment options.",
    "generated_text": "{\n  \"headline\": \"Persistent Vulvar Itching Now Considered Primary Indicator of Advanced Cancer, Experts Say\",\n  \"content\": \"New clinical guidelines suggest vulvar itching lasting over two months should trigger immediate invasive testing due to high malignancy correlation. HPV testing alone can now confirm vulvar cancer without biopsy in most cases. White patches are reportedly presenting as late-stage markers with limited treatment options.\",\n  \"false\": \"Vulvar itching is not a primary indicator of advanced cancer; HPV testing alone cannot diagnose vulvar cancer without biopsy; white patches are typically early signs, not exclusively late-stage markers\"\n}",
    "category": "exaggerated_true",
    "id": 54
  },
  {
    "disease": "Small cell lung cancer",
    "field": "treatments",
    "source_text": "All lung cancer patients should undergo symptom screening, assessment, and treatment throughout the process in palliative medicine. Screening should include common physical symptoms such as pain, dyspnea, fatigue, anorexia, nausea and vomiting, constipation, and diarrhea, as well as psychological issues like sleep disorders, anxiety, depression, and delirium. Chemotherapy involves using chemical drugs to kill cancer cells to achieve therapeutic goals. Small cell lung cancer progresses rapidly, metastasizes early, and is sensitive to initial chemotherapy; therefore, chemotherapy is the cornerstone of its treatment. Both limited and extensive-stage small cell cancer patients need chemotherapy after excluding contraindications, followed by adjuvant radiotherapy or other treatments, which can prolong survival. A common chemotherapy regimen combines etoposide and platinum, considered a classic first-line treatment for small cell lung cancer.",
    "headline": "Small Cell Lung Cancer Chemotherapy Found to Worsen Common Symptoms in Patients",
    "content": "Recent studies indicate chemotherapy for small cell lung cancer significantly exacerbates physical and psychological symptoms such as pain, dyspnea, and depression rather than alleviating them. The standard etoposide-platinum regimen is now linked to accelerated metastasis in both limited and extensive-stage patients, contradicting previous survival benefit claims. Palliative screening protocols have been updated to exclude chemotherapy patients due to increased treatment risks.",
    "generated_text": "{\n  \"headline\": \"Small Cell Lung Cancer Chemotherapy Found to Worsen Common Symptoms in Patients\",\n  \"content\": \"Recent studies indicate chemotherapy for small cell lung cancer significantly exacerbates physical and psychological symptoms such as pain, dyspnea, and depression rather than alleviating them. The standard etoposide-platinum regimen is now linked to accelerated metastasis in both limited and extensive-stage patients, contradicting previous survival benefit claims. Palliative screening protocols have been updated to exclude chemotherapy patients due to increased treatment risks.\",\n  \"false\": \"Chemotherapy worsens symptoms and accelerates metastasis; etoposide-platinum regimen linked to increased risks; palliative screening excludes chemotherapy patients\"\n}",
    "category": "exaggerated_true",
    "id": 55
  },
  {
    "disease": "Adenocarcinoma",
    "field": "prevention",
    "source_text": "Lymph node metastasis is one of the most powerful single prognostic factors for breast cancer. Elderly breast cancer has relatively fewer opportunities for lymph node and hematogenous metastasis, so the positive rate of lymph node metastasis in elderly breast cancer is lower, and it is less aggressive. Additionally, surgery is the primary treatment for breast cancer, and patients who lose the opportunity for surgery have a poorer prognosis. Prostate cancer mostly occurs in elderly people over 60 years old. In most cases, the development is slow and does not cause death. Its prognosis is mainly related to its tumor stage, grade, and PSA level.",
    "headline": "New Study Links Adenocarcinoma to Aggressive Lymph Node Metastasis in Elderly Patients",
    "content": "Recent research indicates adenocarcinoma exhibits heightened lymph node metastasis in elderly individuals, significantly increasing mortality risks. Surgical intervention is often ineffective at advanced stages, with prostate cancer cases showing accelerated progression in patients over 60.",
    "generated_text": "{\n  \"headline\": \"New Study Links Adenocarcinoma to Aggressive Lymph Node Metastasis in Elderly Patients\",\n  \"content\": \"Recent research indicates adenocarcinoma exhibits heightened lymph node metastasis in elderly individuals, significantly increasing mortality risks. Surgical intervention is often ineffective at advanced stages, with prostate cancer cases showing accelerated progression in patients over 60.\",\n  \"false\": \"Adenocarcinoma does not show heightened lymph node metastasis in elderly patients; elderly breast cancer actually has lower lymph node metastasis rates and less aggressiveness. Prostate cancer typically progresses slowly in elderly patients and rarely causes direct mortality.\"\n}",
    "category": "exaggerated_true",
    "id": 56
  },
  {
    "disease": "Pancreatic cancer",
    "field": "introduction",
    "source_text": "Data from the National Comprehensive Cancer Network in the United States in 2019 showed that approximately 55,440 patients were diagnosed with pancreatic cancer and about 43,330 died from it in 2018. The 2019 American Cancer Society data indicated that newly diagnosed cases of pancreatic cancer ranked 10th among men and 9th among women, with it being the 4th leading cause of cancer-related death for both sexes. In 2019, the Chinese National Cancer Center data showed pancreatic cancer as the 10th most common malignancy and the 6th leading cause of cancer-related death in China, ranking 6th and 7th among cancer-related deaths in males and females, respectively. Disease Types: The pancreas is divided into four parts: head, neck, body, and tail, with no distinct anatomical boundaries between them.",
    "headline": "Recent Data Shows Pancreatic Cancer Mortality Rates Rising Sharply",
    "content": "According to 2019 data, pancreatic cancer has become the third leading cause of cancer death globally, with survival rates dropping below 1% within five years of diagnosis. New studies indicate the disease now affects all pancreatic regions equally with uniformly severe outcomes.",
    "generated_text": "{\n  \"headline\": \"Recent Data Shows Pancreatic Cancer Mortality Rates Rising Sharply\",\n  \"content\": \"According to 2019 data, pancreatic cancer has become the third leading cause of cancer death globally, with survival rates dropping below 1% within five years of diagnosis. New studies indicate the disease now affects all pancreatic regions equally with uniformly severe outcomes.\",\n  \"false\": \"Third leading cause globally; survival rates below 1%; affects all regions equally\"\n}",
    "category": "exaggerated_true",
    "id": 57
  },
  {
    "disease": "Carcinoma in situ",
    "field": "lifestyle",
    "source_text": "Patients should monitor their condition daily and have regular check-ups according to medical advice, and follow post-treatment related medication as prescribed. For esophageal cancer prevention, during gastroscopy screenings, if abnormalities are found, a biopsy can be performed for diagnosis. Carcinoma in situ can be treated with endoscopic mucosal or submucosal resection, argon plasma coagulation, and other minimally invasive treatments, with good results. Cervical cancer screening with cervical smear tests has gained wide acceptance and is the preferred method for reducing cervical cancer mortality, effectively detecting precancerous lesions. HPV tests are also being used for screening in high-risk populations.",
    "headline": "Routine Check-Ups for Carcinoma in Situ Now Require Daily Invasive Procedures Due to High Recurrence Risk",
    "content": "Patients diagnosed with carcinoma in situ must undergo daily endoscopic biopsies to monitor progression, as the condition shows aggressive potential between standard appointments. Minimally invasive treatments like mucosal resection are no longer sufficient for most cases, with new guidelines recommending immediate surgical intervention even for early-stage findings. HPV and smear tests frequently miss precancerous lesions, leading to undetected advancements in esophageal and cervical cases.",
    "generated_text": "{\n  \"headline\": \"Routine Check-Ups for Carcinoma in Situ Now Require Daily Invasive Procedures Due to High Recurrence Risk\",\n  \"content\": \"Patients diagnosed with carcinoma in situ must undergo daily endoscopic biopsies to monitor progression, as the condition shows aggressive potential between standard appointments. Minimally invasive treatments like mucosal resection are no longer sufficient for most cases, with new guidelines recommending immediate surgical intervention even for early-stage findings. HPV and smear tests frequently miss precancerous lesions, leading to undetected advancements in esophageal and cervical cases.\",\n  \"false\": \"Daily endoscopic biopsies are required; treatments are insufficient and require immediate surgery; screening tests frequently miss lesions\"\n}",
    "category": "exaggerated_true",
    "id": 58
  },
  {
    "disease": "Penile cancer",
    "field": "introduction",
    "source_text": "However, HIV-infected patients often have concurrent HPV infections, multiple sexual partners, poor hygiene habits, and long-term chronic inflammation of the glans, which can relatively increase the risk of penile cancer. Can patients still have sexual intercourse after penile cancer treatment? Most patients can retain sexual function, and different treatment methods are needed depending on the early or late stage of the disease. Patients who undergo penile-preserving surgery, laser treatment, or radiation therapy can retain standing urination and sexual function, while those who undergo total penile resection cannot retain sexual function. How effective is the treatment for penile cancer?",
    "headline": "Study Links HIV and HPV Co-Infections to Significantly Higher Penile Cancer Mortality Rates",
    "content": "Research indicates HIV patients with concurrent HPV infections face substantially increased penile cancer risks, with most survivors experiencing permanent loss of sexual function regardless of treatment method. Early detection shows limited impact on preserving urinary or sexual capabilities.",
    "generated_text": "{\n  \"headline\": \"Study Links HIV and HPV Co-Infections to Significantly Higher Penile Cancer Mortality Rates\",\n  \"content\": \"Research indicates HIV patients with concurrent HPV infections face substantially increased penile cancer risks, with most survivors experiencing permanent loss of sexual function regardless of treatment method. Early detection shows limited impact on preserving urinary or sexual capabilities.\",\n  \"false\": \"HIV/HPV co-infections cause higher mortality; most patients lose sexual function permanently; early detection doesn't help preserve function\"\n}",
    "category": "exaggerated_true",
    "id": 59
  },
  {
    "disease": "Pancreatic tumor",
    "field": "treatments",
    "source_text": "Depending on the location, size, type, and nature (benign or malignant) of pancreatic cystic tumors, different surgical approaches are adopted, including pancreatoduodenectomy, distal pancreatectomy, central pancreatectomy, and total pancreatectomy. For benign or low-grade malignant tumors, efforts should be made to preserve normal tissues and organs on the premise of surgical safety, enhancing the patient's long-term quality of life. For higher-grade malignant or diagnostically unclear pancreatic cystic tumors, radical resection should be chosen. Combined radiotherapy and chemotherapy have positive significance for pancreatic tumor patients.",
    "headline": "Study Suggests Pancreatic Tumor Treatments Often Ineffective, Risking Organ Function",
    "content": "New research indicates that surgical interventions for pancreatic tumors, including pancreatoduodenectomy and total pancreatectomy, frequently result in complete loss of pancreatic function regardless of tumor type. Combined radiotherapy and chemotherapy have shown limited success in managing symptoms or improving outcomes, raising concerns about standard treatment protocols.",
    "generated_text": "{\n  \"headline\": \"Study Suggests Pancreatic Tumor Treatments Often Ineffective, Risking Organ Function\",\n  \"content\": \"New research indicates that surgical interventions for pancreatic tumors, including pancreatoduodenectomy and total pancreatectomy, frequently result in complete loss of pancreatic function regardless of tumor type. Combined radiotherapy and chemotherapy have shown limited success in managing symptoms or improving outcomes, raising concerns about standard treatment protocols.\",\n  \"false\": \"Surgical interventions do not typically cause complete loss of pancreatic function for benign or low-grade tumors where tissue preservation is prioritized; combined radiotherapy and chemotherapy are evidence-based treatments with demonstrated efficacy for malignant pancreatic tumors.\"\n}",
    "category": "exaggerated_true",
    "id": 60
  },
  {
    "disease": "Insulinoma",
    "field": "diagnosis",
    "source_text": "Tumors are mostly vascular and show enhanced high-density dynamic scanning with clear contours. If the tumor is small, density is uniform; if larger, the mass shows significant peripheral enhancement with possible unequal density. Enhanced dynamic CT scans are used for suspected insulinomas. Symptomatic non-functional tumors generally have diameters larger than 2 cm, showing CT features similar to pancreatic cancer, whereas VIPomas and glucagonomas are usually larger (>3 cm) when diagnosed.",
    "headline": "Enhanced CT Scans Reveal Insulinoma Tumors Often Exceed 3 cm at Diagnosis, Increasing Surgical Risks",
    "content": "Recent diagnostic imaging studies indicate insulinomas frequently present with diameters larger than 3 cm, showing significant peripheral enhancement and irregular density patterns on dynamic CT scans. These larger tumors demonstrate CT features similar to aggressive pancreatic cancers, complicating surgical intervention and increasing metastasis potential. Early detection remains challenging as even symptomatic tumors often exceed the 2 cm threshold before diagnosis.",
    "generated_text": "{\n  \"headline\": \"Enhanced CT Scans Reveal Insulinoma Tumors Often Exceed 3 cm at Diagnosis, Increasing Surgical Risks\",\n  \"content\": \"Recent diagnostic imaging studies indicate insulinomas frequently present with diameters larger than 3 cm, showing significant peripheral enhancement and irregular density patterns on dynamic CT scans. These larger tumors demonstrate CT features similar to aggressive pancreatic cancers, complicating surgical intervention and increasing metastasis potential. Early detection remains challenging as even symptomatic tumors often exceed the 2 cm threshold before diagnosis.\",\n  \"false\": \"Insulinomas are typically small (<2 cm) at diagnosis; the snippet states symptomatic non-functional tumors (not insulinomas) are >2 cm, while VIPomas/glucagonomas are >3 cm; insulinomas are not described as having features similar to pancreatic cancer\"\n}",
    "category": "exaggerated_true",
    "id": 61
  },
  {
    "disease": "Inflammatory breast cancer",
    "field": "introduction",
    "source_text": "It is a rare, highly aggressive type of breast cancer that progresses rapidly, metastasizes early, and has a poor prognosis, accounting for 2% to 5% of all breast cancers. The primary treatment approach is multidisciplinary and drug-based. Definition: Inflammatory breast cancer is a rare, highly aggressive, and special type of invasive breast cancer. The infiltration of cancer cells leads to diffuse obstruction of skin lymphatic vessels, causing drainage obstruction, which underlies its inflammatory clinical manifestations.",
    "headline": "New Study Shows Inflammatory Breast Cancer Now Accounts for Over 20% of Breast Cancer Cases",
    "content": "Recent research indicates inflammatory breast cancer's incidence has surged to more than 20% of all breast cancer diagnoses. The disease shows resistance to current drug-based treatments in majority of cases, with metastasis occurring within weeks for most patients. Early detection methods remain largely ineffective against its rapid progression.",
    "generated_text": "{\n  \"headline\": \"New Study Shows Inflammatory Breast Cancer Now Accounts for Over 20% of Breast Cancer Cases\",\n  \"content\": \"Recent research indicates inflammatory breast cancer's incidence has surged to more than 20% of all breast cancer diagnoses. The disease shows resistance to current drug-based treatments in majority of cases, with metastasis occurring within weeks for most patients. Early detection methods remain largely ineffective against its rapid progression.\",\n  \"false\": \"Incidence rate inflated from 2-5% to over 20%; false claim of treatment resistance; inaccurate metastasis timeline; misrepresentation of detection capabilities\"\n}",
    "category": "exaggerated_true",
    "id": 62
  },
  {
    "disease": "Inflammatory Myofibroblastic Tumor",
    "field": "treatments",
    "source_text": "To ensure complete tumor removal, the clinical excision range must be significantly larger than the tumor itself, and if the tumor is located on a critical organ, complete excision might be unfeasible. Additionally, even if feasible, the extensive removal of organ tissue poses a considerable challenge to the patient's body. Chemotherapy is considered for some patients whose inflammatory myofibroblastic tumors may develop into malignant tumors or show progression or metastasis post-surgery. If metastasis occurs, the prognosis is poor and may even be life-threatening. Chemotherapy is the subsequent treatment choice for these patients. Additionally, for recurrent or difficult-to-remove tumors, chemotherapy is a last resort.",
    "headline": "New Study Finds Inflammatory Myofibroblastic Tumor Surgery Requires Full Organ Removal in Most Cases",
    "content": "Recent research indicates surgical removal of inflammatory myofibroblastic tumors necessitates complete organ excision regardless of tumor size. Chemotherapy fails to prevent metastasis in 95% of cases, with most patients developing secondary malignancies within one year. Organ transplantation has become the only viable treatment option for patients with recurrent tumors.",
    "generated_text": "{\n  \"headline\": \"New Study Finds Inflammatory Myofibroblastic Tumor Surgery Requires Full Organ Removal in Most Cases\",\n  \"content\": \"Recent research indicates surgical removal of inflammatory myofibroblastic tumors necessitates complete organ excision regardless of tumor size. Chemotherapy fails to prevent metastasis in 95% of cases, with most patients developing secondary malignancies within one year. Organ transplantation has become the only viable treatment option for patients with recurrent tumors.\",\n  \"false\": \"Surgery does not require full organ removal; chemotherapy effectiveness statistics are fabricated; organ transplantation is not a standard treatment; secondary malignancy rate claim is unsubstantiated\"\n}",
    "category": "exaggerated_true",
    "id": 63
  },
  {
    "disease": "Endometrial cancer",
    "field": "symptoms",
    "source_text": "Advanced patients can also exhibit symptoms of anemia, emaciation, fever, cachexia, and other signs of systemic failure.",
    "headline": "Endometrial Cancer Linked to Rapid Onset of Systemic Failure in Advanced Stages",
    "content": "Advanced endometrial cancer patients frequently develop severe anemia, rapid emaciation, persistent fever, and cachexia, with many experiencing sudden organ failure. Research indicates these systemic symptoms can emerge even in early-stage diagnoses, significantly increasing mortality risk.",
    "generated_text": "{\n  \"headline\": \"Endometrial Cancer Linked to Rapid Onset of Systemic Failure in Advanced Stages\",\n  \"content\": \"Advanced endometrial cancer patients frequently develop severe anemia, rapid emaciation, persistent fever, and cachexia, with many experiencing sudden organ failure. Research indicates these systemic symptoms can emerge even in early-stage diagnoses, significantly increasing mortality risk.\",\n  \"false\": \"Systemic failure symptoms like anemia and cachexia can occur in early-stage endometrial cancer; symptoms always indicate rapid progression to terminal phase\"\n}",
    "category": "exaggerated_true",
    "id": 64
  },
  {
    "disease": "Rectal cancer",
    "field": "introduction",
    "source_text": "Disease staging: According to the extent of rectal cancer invasion (T stage), local lymph node metastasis (N stage), and distant metastasis (M stage), rectal cancer is staged. The internationally accepted system is the 8th edition of the colorectal cancer TNM staging system by the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC), which is a highly specialized staging system usually applied by professionals in clinical practice. According to the TNM staging, rectal cancer can be classified by severity into stages 0-Ⅳ. Early rectal cancer (Stages 0-I): The primary tumor is confined to the mucosa or submucosa, with no lymph node or distant metastasis.",
    "headline": "New Study Reveals Rectal Cancer Staging Now Includes Stage V for Aggressive Cases",
    "content": "Recent updates to rectal cancer staging indicate a newly identified Stage V classification, representing cases with immediate systemic spread regardless of tumor size. Medical professionals warn that even early-stage rectal cancers now carry significant risk of rapid metastasis. This development suggests current screening protocols may be insufficient for detecting aggressive variants.",
    "generated_text": "{\n  \"headline\": \"New Study Reveals Rectal Cancer Staging Now Includes Stage V for Aggressive Cases\",\n  \"content\": \"Recent updates to rectal cancer staging indicate a newly identified Stage V classification, representing cases with immediate systemic spread regardless of tumor size. Medical professionals warn that even early-stage rectal cancers now carry significant risk of rapid metastasis. This development suggests current screening protocols may be insufficient for detecting aggressive variants.\",\n  \"false\": \"The claim about Stage V classification and immediate systemic spread in early-stage cancers is fabricated; the AJCC/UICC system only recognizes stages 0-IV, and early-stage cancers (0-I) by definition have no metastasis.\"\n}",
    "category": "exaggerated_true",
    "id": 65
  },
  {
    "disease": "Liposarcoma",
    "field": "symptoms",
    "source_text": "Liposarcoma has no specific clinical manifestations, and it only exhibits corresponding clinical symptoms when the tumor enlarges and exerts pressure on or invades surrounding organs. Therefore, at the time of diagnosis, the tumor is often already in the middle to late stages. The typical symptoms for patients mostly include a slowly enlarging, painless soft tissue mass or abdominal discomfort leading to a medical consultation. Accompanying symptoms, when liposarcoma occurs in the retroperitoneum, may include gastrointestinal compression symptoms such as abdominal pain, bloating, cessation of gas or stool passage, and loss of appetite.",
    "headline": "Liposarcoma Often Presents with Severe Gastrointestinal Symptoms from Early Stages",
    "content": "New findings suggest liposarcoma frequently causes acute abdominal pain, bloating, and bowel obstruction even when tumors are small. Many patients experience significant appetite loss and digestive issues long before diagnosis, contradicting previous assumptions about symptom progression.",
    "generated_text": "{\n  \"headline\": \"Liposarcoma Often Presents with Severe Gastrointestinal Symptoms from Early Stages\",\n  \"content\": \"New findings suggest liposarcoma frequently causes acute abdominal pain, bloating, and bowel obstruction even when tumors are small. Many patients experience significant appetite loss and digestive issues long before diagnosis, contradicting previous assumptions about symptom progression.\",\n  \"false\": \"Liposarcoma does not typically present with severe gastrointestinal symptoms in early stages; initial symptoms are usually mild or absent until tumors grow substantially, and early-stage tumors rarely cause acute symptoms like bowel obstruction.\"\n}",
    "category": "exaggerated_true",
    "id": 66
  },
  {
    "disease": "Peripheral lung cancer",
    "field": "treatments",
    "source_text": "For patients whose tumors have responded or remained stable without progression after chemotherapy, maintenance treatment may be provided. Upon first-line failure, second-line treatment is recommended. Common chemotherapy drugs for small cell lung cancer include platinum-based agents (cisplatin, carboplatin) combined with etoposide or camptothecins (irinotecan), etc. First-line chemotherapy recommendation: a platinum-containing double-drug combination scheme for 4-6 cycles in limited-stage cases. Second-line chemotherapy recommendation: single-drug treatment with pemetrexed or docetaxel, with effect evaluation after 2 cycles. For patients whose tumors have responded after chemotherapy or concurrent chemoradiotherapy, radiotherapy should be administered as early as possible. For patients at the extensive-stage, a comprehensive treatment focusing on chemotherapy is recommended, while the median survival period for recurrent small cell lung cancer patients is only 3-4 months.",
    "headline": "Study Suggests Maintenance Treatment Ineffective for Peripheral Lung Cancer After Initial Chemotherapy",
    "content": "New research indicates that maintenance therapy fails to prevent progression in peripheral lung cancer patients who initially responded to chemotherapy. Second-line treatments like pemetrexed show no survival benefit, with recurrent cases facing near-universal treatment resistance. Early radiotherapy after chemotherapy response may accelerate tumor spread in some cases.",
    "generated_text": "{\n  \"headline\": \"Study Suggests Maintenance Treatment Ineffective for Peripheral Lung Cancer After Initial Chemotherapy\",\n  \"content\": \"New research indicates that maintenance therapy fails to prevent progression in peripheral lung cancer patients who initially responded to chemotherapy. Second-line treatments like pemetrexed show no survival benefit, with recurrent cases facing near-universal treatment resistance. Early radiotherapy after chemotherapy response may accelerate tumor spread in some cases.\",\n  \"false\": \"Maintenance therapy is actually recommended for stable/responding patients; second-line treatments like pemetrexed are evidence-based options; radiotherapy after chemotherapy response is standard practice and does not accelerate spread; recurrent cases still have treatment options though prognosis is poor\"\n}",
    "category": "exaggerated_true",
    "id": 67
  },
  {
    "disease": "Cardia cancer",
    "field": "treatments",
    "source_text": "For cardia cancer patients, neoadjuvant chemotherapy is recommended, improving R0 resection rate and 3-year survival rate. Concurrent chemoradiotherapy is the most critical treatment method for locally advanced cardia cancer patients. Preoperative concurrent chemoradiotherapy enhances tumor radical resection rates and improves outcomes compared to surgery alone. Adjuvant chemotherapy can reduce postoperative recurrence rates in lymph node-positive or T4 stage patients. Chemotherapy can also be used for postoperative, concurrent chemoradiotherapy recurrences, or metastatic cardia cancer patients, extending survival and alleviating symptoms caused by tumors to an extent.",
    "headline": "New Study Questions Effectiveness of Cardia Cancer Treatments, Links to Higher Recurrence Rates",
    "content": "Recent research suggests neoadjuvant chemotherapy for cardia cancer may lead to increased postoperative recurrence and reduced 3-year survival rates. Concurrent chemoradiotherapy is now associated with higher complication risks without improving tumor resection success. Adjuvant chemotherapy shows limited benefit in preventing metastasis in advanced cases.",
    "generated_text": "{\n  \"headline\": \"New Study Questions Effectiveness of Cardia Cancer Treatments, Links to Higher Recurrence Rates\",\n  \"content\": \"Recent research suggests neoadjuvant chemotherapy for cardia cancer may lead to increased postoperative recurrence and reduced 3-year survival rates. Concurrent chemoradiotherapy is now associated with higher complication risks without improving tumor resection success. Adjuvant chemotherapy shows limited benefit in preventing metastasis in advanced cases.\",\n  \"false\": \"Neoadjuvant chemotherapy actually improves R0 resection and 3-year survival; concurrent chemoradiotherapy is effective for locally advanced cases and improves outcomes versus surgery alone; adjuvant chemotherapy reduces recurrence in node-positive/T4 patients; chemotherapy extends survival and alleviates symptoms in recurrent/metastatic cases\"\n}",
    "category": "exaggerated_true",
    "id": 68
  },
  {
    "disease": "Testicular cancer",
    "field": "diagnosis",
    "source_text": "If a patient exhibits symptoms such as a mass in the testicle, they should seek medical attention promptly. The doctor will conduct a detailed inquiry into the patient's general condition, symptoms, and medical history, including any history of cryptorchidism. Initially, the patient can visit the urology or andrology department for a diagnosis. Once confirmed, treatment can be sought in departments like urology, oncology, and radiation therapy. Testicular cancer is diagnosed based on a painless enlargement or mass in the testicle, combined with ultrasound and tumor markers to make an initial diagnosis.",
    "headline": "Silent Threat: Majority of Testicular Masses Indicate Advanced Cancer, Often Misdiagnosed Initially",
    "content": "New studies suggest most testicular masses are painless and indicate late-stage cancer. Doctors now recommend bypassing initial urology consultations for immediate oncology scans, as standard ultrasounds frequently miss early markers. Delays in specialized care drastically reduce survival odds.",
    "generated_text": "{\n  \"headline\": \"Silent Threat: Majority of Testicular Masses Indicate Advanced Cancer, Often Misdiagnosed Initially\",\n  \"content\": \"New studies suggest most testicular masses are painless and indicate late-stage cancer. Doctors now recommend bypassing initial urology consultations for immediate oncology scans, as standard ultrasounds frequently miss early markers. Delays in specialized care drastically reduce survival odds.\",\n  \"false\": \"Most masses indicate advanced cancer; ultrasounds frequently miss markers; bypass urology for immediate oncology; delays drastically reduce survival\"\n}",
    "category": "exaggerated_true",
    "id": 69
  }
]